Novel Progestin Signaling Molecules in the Brain: Distribution, Regulation and Molecular Mechanism of Action by Intlekofer, Karlie A
University of Massachusetts Amherst
ScholarWorks@UMass Amherst
Open Access Dissertations
5-13-2011
Novel Progestin Signaling Molecules in the Brain:
Distribution, Regulation and Molecular
Mechanism of Action
Karlie A. Intlekofer
University of Massachusetts Amherst
Follow this and additional works at: https://scholarworks.umass.edu/open_access_dissertations
Part of the Molecular and Cellular Neuroscience Commons
This Open Access Dissertation is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in
Open Access Dissertations by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
Intlekofer, Karlie A., "Novel Progestin Signaling Molecules in the Brain: Distribution, Regulation and Molecular Mechanism of
Action" (2011). Open Access Dissertations. 366.
https://scholarworks.umass.edu/open_access_dissertations/366
  
NOVEL PROGESTIN SIGNALING MOLECULES IN THE BRAIN: 
DISTRIBUTION, REGULATION AND MOLECULAR  
MECHANISM OF ACTION 
 
 
 
 
 
A Dissertation Presented  
by 
KARLIE A. INTLEKOFER 
 
 
Submitted to the Graduate School of the 
University of Massachusetts Amherst in partial fulfillment 
of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
May 2011 
 
Neuroscience and Behavior Program 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Karlie A. Intlekofer 2011 
 
All Rights Reserved 
 
NOVEL PROGESTIN SIGNALING MOLECULES IN THE BRAIN: 
DISTRIBUTION, REGULATION AND MOLECULAR  
MECHANISM OF ACTION 
 
 
A Dissertation Presented 
by 
KARLIE A. INTLEKOFER 
 
Approved as to style and content by: 
 
_____________________________________ 
Sandra L. Petersen, Chair 
 
 
______________________________________ 
John J. Peluso, Member 
 
 
______________________________________ 
Pablo E. Visconti, Member 
 
 
_______________________________________ 
Rolf O. Karlstrom, Member 
 
 
 
__________________________________________ 
Jerry Meyer, Department Head 
Neuroscience and Behavior Program 
 
 
DEDICATION 
 
 
To Mom, Dad, Dan, Adrien, Jay and my closest friends, for their love and support
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
ACKNOWLEDGMENTS 
 
I would like to thank Dr. Sandy Petersen, who has served as a supportive mentor 
and guided me through the doctorate and publishing process.  Sandy has provided 
invaluable insight into my work while allowing me to explore many different techniques 
and approaches.  Her ability to provide a challenging and creative work environment 
have allowed me to grow as a researcher and as an individual.  
I would like to thank my labmates, past and present, in the Petersen lab: Eser 
Yilmaz, Sudha Krishnan, Leah Aggison, Evelyn Santos, Sarah Fadden, Jinyan Cao, Lan 
Ji, Michael Cunningham, and Drs. Maristela Poletini, Paula Moura, Javier Del Pino and 
Kay Son.  I give special thanks to Ted Hudgens, who taught me important techniques and 
shared ideas and advice.  I am also very thankful for Michael Cunningham, Paula Moura, 
Leah Aggison and Emily Merchasin for their unwaning friendship and support.    
I am very grateful to Dr. Thomas Zoeller and members of his laboratory.  In 
particular, Dave Sharlin, Judy Brewer, Ruby Bansal and Stephanie Giera have provided 
helpful insights that have aided in producing this work.  I also want to recognize fellow 
NSB graduate students Bryan Olson, Carrie Mahoney, Patrick Taylor and Thalia Gilbert 
for helpful insight and support, as well as thought-provoking discussions and laughter. 
I am thankful to Drs. John J. Peluso, Pablo Visconti and Rolf Karlstrom for their 
generous gift of time and expertise as committee members.  I thank the Neuroscience and 
Behavior Program for providing a diverse research environment and their help and 
support in completing this work.  Finally, I thank SAPAI and all associated staff for their 
support in organizing and writing this document.
vi 
ABSTRACT 
NOVEL PROGESTIN SIGNALING MOLECULES IN THE BRAIN: 
DISTRIBUTION, REGULATION AND MOLECULAR  
MECHANISM OF ACTION 
 MAY 2011 
KARLIE A. INTLEKOFER, BS. COLORADO STATE UNIVERSITY 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Sandra L. Petersen 
Progesterone regulates female reproduction in many ways, yet it is still unclear 
how signals are conveyed through nuclear and extranuclear receptors.  The traditional 
notion was that progesterone binds classical progesterone receptors to alter gene 
transcription.  This view has been challenged by the discovery of additional progesterone 
signaling molecules important for progesterone actions in non-neural cells.  In granulosa 
cells, the progesterone receptor membrane component 1 (Pgrmc1) mediates progesterone 
effects by forming a receptor complex with binding partner, Serpine mRNA binding 
protein 1, but it is unknown whether these molecules function similarly in the brain.  To 
begin to address these issues, I investigated the neural role of Pgrmc1 in female mouse 
brain, rat brain and in neural cells. By examining the neuroanatomical localization, 
hormonal regulation, and colocalization of Pgrmc1 within key neurons in the neural 
control of ovulation, Pgrmc1 emerged as a candidate signaling molecule likely to mediate 
progesterone functions.  Furthermore, Pgrmc1 levels regulate the expression of several 
diverse genes and signaling pathways in neural cells.  Taken together, these results 
demonstrate that Pgrmc1 function is likely to impact diverse neural functions.
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CHAPTER 1 
PROGESTIN MECHANISM OF ACTION IN THE CNS 
1.1 Introduction  
The term “progestins” refers to a class of steroid hormones first named for a  
role in maintaining pregnancy (Allen and Wintersteiner, 1934).  Current research shows 
that progestins are critical for many aspects of female reproduction and also involved in 
diverse non-reproductive physiological processes.  In addition, emerging data suggest 
that progestins act in the central nervous system and affect a wide range of neural 
functions, such as the neural control of ovulation, sexual behaviors and neuroprotection.  
Despite the prominent role of progestins and the long history of research on this 
hormone, the mechanisms that underlie progestin cellular actions remain an area of 
active research.  This chapter will review progestin mechanisms of action and focus on 
signaling molecules that may mediate the neural effects of progestin in females.         
1.2 Sources and Synthesis 
Progestins vary widely in their chemical structures, and may be classified into 
natural and synthetic types.  The natural progestin, progesterone (P4), is a hormone 
produced in the gonads, adrenal glands, and central nervous system.  P4 is an 
intermediate in the production of mineralocorticoids, glucocorticoids, androgens and 
estrogens.  The key reactions in P4 biosynthesis can be viewed in Figure 1.  Like other 
steroid hormones, the synthesis of P4 begins with cholesterol as a substrate.  Cholesterol 
is transported from the outer to the inner mitochondrial membrane by the steroid acute 
regulatory protein (StAR) (Clark et al., 1994).  StAR is activated by a phosphorylation 
event and this is regarded as the rate-limiting step in steroidogenesis.  Once transported 
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to the inner mitochondrial 
membrane, a P450 side chain 
cleavage enzyme (P450scc) 
converts cholesterol to 
pregnenolone by removal of the 
C-27 cholesterol side chain 
(Juengel et al., 1995, Niswender, 
2002).  Through the actions of 3β-
hydroxysteroid dehydrogenase 
(3β-HSD), pregnenolone is 
converted to P4.  While diverse 
cells are capable of P4 production, 
the stimulatory factors that drive 
this process are tissue-specific.   
1.2.3 The Nervous System 
 The idea of neurosteroid production has been supported by studies for over 50 
years.  Some of the early studies on this topic showed that the central nervous systems 
contains factors necessary for steroidogenesis including cholesterol sulfate (Iwamori et 
al., 1976), aromatase (Denef et al., 1973), steroid-5α-reductase (Jaffe, 1969, Sholiton 
and Werk, 1969), steroid hydroxylases (Guiraud et al., 1979, Fishman et al., 1980), 
hydroxysteroid dehydrogenase and steroid dehydroxylases (Knapstein et al., 1968).  
Another early study showed that pregnenolone levels remain elevated above plasma 
levels in the rat brain, even after gonadectomy and adrenalectomy (Corpechot et al., 
Figure 1.2.1:  Progesterone
 
Biosynthetic Pathway 
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1981, Corpechot et al., 1983).  Thus, early data suggested that progesterone is produced 
within the nervous system. 
More recent evidence supports this concept.  For example, P4 can be produced 
by oligodendrocytes and neurons, though astrocytes are the main steroidogenic cells of 
the brain (Zwain and Yen, 1999).  These brain cells contain enzymes required for P4 
synthesis (Karri et al., 2007), many of which are sensitive to 17β-estradiol (E2).  E2 
increases 3β-HSD expression and activity in female rat hypothalamus (Micevych et al., 
2003).  In astrocytes, E2 activates protein kinases that mediate StAR phosphorylation, 
resulting in P4 production (Sinchak et al., 2003, Boulware et al., 2005, Micevych et al., 
2007).  Although the stimuli for P4 synthesis vary by tissue, most steroidogenic 
pathways require activation of phosphorylation cascades that activate StAR and other 
steroidogenic enzymes.   
In the peripheral nervous system, similar mechanisms enable neurons and 
Schwann cells to produce P4.  Schwann cells possess the enzymes necessary for 
synthesis of P4 (Guennoun et al., 1997), and produce this steroid hormone following 
neuronally-derived cues (Robert et al., 2001).  These cues are not yet known, but neural 
input to Schwann cells is necessary for P4 synthesis and maintain myelination (Chan et 
al., 1998b).  Following acute trauma, such as axonal injury, Schwann cells are 
stimulated to increase P4 production (Koenig et al., 1995).  In turn, the P4 provides 
neuroprotective benefits including decreased cell death and increased myelin repair 
(Labombarda et al., 2006)  Thus, P4 biosynthesis in the nervous system may provide 
important neuroprotective effects that aid in myelin formation.   
 4 
 
1.3 Effects of P4 in the Central Nervous System 
 Although the effects of P4 in the brain are diverse, much of the research focuses 
on two main topics: the important role of P4 in neuroprotection and in female 
reproduction.  The therapeutic potential of understanding P4 actions is highlighted by 
studies involving brain injury and age-related disease.  Additionally, the role of P4 in the 
neural control of ovulation and feminine sex behaviors have been intensely studied in 
the field of neuroendocrinology.  A summary of these studies is provided in the 
following sections. 
1.3.1 Neuroprotection 
 Though the exact mechanisms are not yet clear, the findings of many studies 
support the idea the therapeutic P4 administration following traumatic brain injury, 
stroke or spinal cord trauma improves recovery.  For example, P4 downregulates 
inflammatory cascades and decreases proapoptotic gene expression when administered 
following traumatic brain injury (He et al., 2004, Pettus et al., 2005, Guo et al., 2006, 
O'Connor et al., 2007).  Additionally, P4 reduces edema through a protective and 
reparative effect on the blood brain barrier, a structure with cells especially vulnerable 
to damage (Wahl et al., 1993).  Damage to this structure increases edema, and P4 exerts 
protective effects by inhibiting ion transport and reducing free radical-induced damage 
of the blood brain barrier cells (Betz and Coester, 1990a, b, Hoffman et al., 1996).  
Thus, P4 may benefit and improve several components necessary for brain healing 
following trauma.  
Many mechanisms of P4 action have been proposed based on observations that 
P4 treatment limits tissue damage and improves functional outcomes.  Early on, studies 
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showed that P4 metabolites activate GABAA receptors, thereby reducing excessive 
excitotoxicity (Kokate et al., 1994).  The beneficial role of P4 in recovery is likely to 
involve the classical P4 receptor as demonstrated by studies using transgenic animals 
(Jodhka et al., 2009).  Although continuing work focuses on these mechanisms, the use 
of P4 as a therapeutic strategy has already been demonstrated in many animal studies 
(Gibson et al., 2008).  Such findings led to clinical research in human patients and 
showed P4 administration in victims of traumatic brain injury lowers mortality and may 
decrease disability levels (Wright et al., 2007).  Further clinical studies are underway 
and research continues to reveal the mechanisms through which P4 benefits neuronal 
survival.     
1.3.2 Reproductive Functions 
While the functions of P4 are diverse, this hormone is primarily known for its 
role in female reproduction.  Many P4 effects, including the generation of luteinizing 
hormone (LH) surge that precedes ovulation, require the contribution of E2.  Ovarian 
follicles are stimulated to grow by follicle stimulating hormone each cycle, producing 
increasing levels of E2 that feed back onto cells of the hypothalamus and anterior 
pituitary.  E2 positive feedback results in peak E2 levels that increase the firing rate of 
gonadotropin releasing hormone (GnRH) neurons (Christian et al., 2005).  This process 
is likely to involve the preoptic area (POA), a region that contains the anteroventral 
periventricular nucleus (AVPV).  Ablation studies (Wiegand et al., 1980, Ronnekleiv 
and Kelly, 1986) or estrogen deprivation (Petersen et al., 1989)  in the AVPV blocks 
LH surge, and neurons of the AVPV contain most of the E2 receptors in the POA and 
provide E2-sensitive input to GnRH neurons (Simonian et al., 1999, Ottem et al., 2004).  
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In the AVPV, E2 induces expression of the classical P4 receptor (Pgr), (Simerly et al., 
1996, Hagihara et al., 1992, Shughrue et al., 1997), an induction required for the GnRH 
hyperactivation, LH surge release (Chappell and Levine, 2000) and ovulation.  The 
ruptured follicle that remains forms a corpus luteum that produces additional P4.  While 
circulating P4 activates the Pgr, the ligand-independent activation of the Pgr by neural 
signals is thought to be also critical for the LH surge mechanism (Mani et al., 1994a, 
Mani et al., 1996). Thus, the E2-dependent Pgr induction and possibly ligand-
independent activation of PR are crucial for the preovulatory LH surge.  
 
While studies in ovariectomized rats show that E2 treatment alone is sufficient 
for a blunted daily LH surge, P4 treatment administration to E2-primed rats rapidly 
advances the onset of ovulation, and increases the magnitude and duration of the LH 
surge (Everett, 1948, Rothchild, 1965, DePaolo and Barraclough, 1979).  Interestingly, 
intact animals do not exhibit significantly increased circulating P4 levels preceding the 
LH surge (Smith et al., 1975, Park and Ramirez, 1987).  Pgr activation is required for 
LH surge initiation, and may occur by ligand-independent manner through neural 
activity (Chappell et al., 2000).  Another recent possibility is that hypothalamic P4 
production activates E2-induced Pgrs in the intact animal.  This idea is supported by the 
finding that LH surge levels are correlated with hypothalamic P4 concentrations, an 
observation that persists in animals that lack ovarian and adrenal sources of P4 
(Micevych et al., 2003, Micevych and Sinchak, 2008).  Finally, the LH surge can be 
blocked by hypothalamic administration of P4 synthesis inhibitors (Snyder et al., 1984, 
DePaolo, 1988, Hibbert et al., 1996).  Together these data suggest that both the E2-
induction of Pgr and neuroprogesterone synthesis may be requisite steps in the LH 
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surge mechanism.  Though many studies have investigated the role of P4 in this process, 
the possibility that P4 signaling molecules may mediate the rapid advancement and 
amplification of the surge remains untested.   
 Beyond a role in the neural control of ovulation, P4 is also implicated in the 
coordinated facilitation of reproductive sex behaviors that accompany ovulation.  
Following E2-priming, P4 activation of Pgr within the ventromedial nucleus of the 
hypothalamus (VMN) induces lordosis, a stereotypical receptive posture (Whalen, 
1974, Moguilewsky and Raynaud, 1979, Pfaff and Sakuma, 1979, Hoshina et al., 1994).  
Similar to the LH surge mechanism, this P4 effect requires to E2-induction of the Pgr, 
underscoring the important transcriptional role of E2 (Parsons et al., 1980, Pollio et al., 
1993, Mani et al., 1994b, Ogawa et al., 1994).  Interestingly, membrane-active P4 
metabolites and membrane impermeable P4-BSA are also capable of facilitating 
receptive behaviors in E2-primed rats (Rodriguez-Manzo et al., 1986, Ke and Ramirez, 
1987), suggesting that additional mechanisms of P4 actions synchronize ovulation and 
the expression of feminine sex behaviors.  Rapid membrane-initiated P4 signaling may 
be mediated through progestin signaling molecules, though this possibility has not yet 
been explored.  While clues as to these behaviors continue to emerge, it is clear that Pgr 
induction is a critical component in the control of sex behavior. 
1.4 The Classical Progesterone Receptor (Pgr) 
Studies using Pgr knockout mice show that the classical Pgr mediates many P4 
effects in reproductive tissues (Ismail et al., 2003).  The Pgr gene is expressed as two 
protein isoforms, A and B, that have identical ligand- and DNA-binding 
domains.  These isoforms only differ in that Pgr B has an additional 164 amino acids at 
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the C-terminus (Kastner et al., 1990).  Results of studies in Pgr knockouts predict that 
each splice variant has distinct reproductive roles.  For example, Pgr A knockouts are 
characterized by ovary and implantation defects, while Pgr B knockouts show 
proliferative defects in the mammary gland and uterus (Shyamala et al., 1998, Mulac-
Jericevic et al., 2000, Mulac-Jericevic et al., 2003).  The ratio of A and B isoforms also 
appears to be important for normal growth and development, and disruption of this ratio 
is a common feature of human breast cancers (Mote et al., 2004).  Though these studies 
address the roles of specific Pgr isoforms, the interpretation of such findings is 
complicated due to developmental differences and compensation inherent to body-wide 
gene targeting approaches. 
             Though Pgr is a member of the nuclear receptor superfamily of transcription 
factors (Evans, 1988, Tsai et al., 1988), not all Pgr-dependent P4 effects include 
delayed-onset transcriptional events.  Short latency Pgr-dependent effects have also 
been observed (Meyerson, 1972, Kubli-Garfias and Whalen, 1977, Schumacher et al., 
1990), and they do not require Pgr DNA-binding activity.  Specific examples include 
findings that P4 binds Pgrs to activate phospholipase C and kinase Cdk1 in enucleated 
amphibian oocytes (Schuetz, 1977, Bayaa et al., 2000, Morrison et al., 2000).  In 
mammalian cell lines, P4 causes Pgr-dependent activation of p60-Src kinase within 
minutes (Migliaccio et al., 1998), and also rapidly and transiently activates MAPK 
signaling (Boonyaratanakornkit et al., 2001).  Such findings prompted revision of the 
traditional tenet of steroid hormone action (Truss and Beato, 1993), as the mechanism 
of Pgr action extends beyond gene transcription. 
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 Efforts to understand the extranuclear actions of Pgr have shown that 
polyproline motifs of the Pgr enable interactions with Src, a tyrosine kinase 
(Boonyaratanakornkit et al., 2001).  This interaction between Pgr and Src does not 
require Pgr-DNA binding nor transcription, suggesting that the Pgr plays dual roles in 
cell signaling and transcription that are distinct and separable (Edwards et al., 
2002).  Although both Pgr isoforms have identical Src-interacting polyproline motifs, 
the A isoform is predominantly located in the nucleus and is not capable of activating 
Src (Boonyaratanakornkit et al., 2007).  Thus, it is likely that the ratio of Pgr isoforms, 
along with tissue-specific factors, contribute to nuclear and extra-nuclear P4 actions in 
the brain and reproductive tissues.  Importantly, additional P4 signaling molecules may 
impact Pgr function.  These findings underscore the complexity of Pgr-dependent P4 
signaling and suggest that multiple signaling mechanisms may mediate diverse P4 
actions.   
1.5 Progesterone Receptor Membrane Component-1 (Pgrmc1) 
Pgrmc1 is a progestin signaling molecule that was discovered in several 
unrelated biological contexts, resulting in interesting clues as to physiological functions, 
but also many synonyms (Losel et al., 2003, Min et al., 2004, Cahill, 2007).  Pgrmc1 
encodes a 28-kDa protein that is often isolated as a 56-kDa dimer, and contains a single 
N-terminal membrane-spanning domain, a cytochrome b5-like or steroid/heme binding 
domain (Mifsud and Bateman, 2002).  This protein has been localized to the plasma 
membrane (Peluso et al., 2006), endoplasmic reticulum (ER) (Falkenstein et al., 1998), 
and nucleus (Beausoleil et al., 2004).  Pgrmc1 has been implicated in a wide array of 
physiological processes, leading to the publication of many reviews despite limited 
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understanding of its exact cellular roles (Craven, 2008, Guennoun et al., 2008, 
Sakamoto et al., 2008, Rohe et al., 2009). 
Among the first identified Pgrmc1 functions is a role in steroidogenesis, an idea 
supported by studies in several cell types that demonstrate associations with 
endoplasmic reticulum (ER) proteins (Laird et al., 1988, Nolte et al., 2000).  In adrenal 
gland cells, Pgrmc1 may be required for activities of CYP21 and CYP11B1 (Min et al., 
2004), two cytochrome P450 enzymes that catalyze the 21-hydroxylation of P4 and 18-
hydroxylation of deoxycorticosterone, respectively (Barker et al., 1992).  In yeast, the 
Pgrmc1 homologue binds and activates CYP51A1, an enzyme that controls the rate of 
cholesterol synthesis (Hughes et al., 2007).  Additionally, the same authors showed that 
Pgrmc1 activates Erg5/CYP61A1, another P450 protein in the cholesterol synthesis 
pathway.  In COS7 kidney cells, Pgrmc1 binds to insulin-induced gene and SREBP 
cleavage activating protein, two endoplasmic reticulum proteins critical for cholesterol 
homeostasis (Suchanek et al., 2005, Goldstein et al., 2006).  Additional evidence that 
supports a role in cholesterol or steroid metabolism is that Pgrmc1 is found in cells of 
the zona fasciculata/reticularis (adrenal gland), Leydig cells and hepatocytes (Raza et 
al., 2001).   
The brain is another location found to express Pgrmc1, and several studies have 
identified potential roles for Pgrmc1 in steroidogenesis within particular neurons.  
Cerebellar Purkinje cells contain P450scc, 3β-HSD and StAR, and produce P4 during 
development that is correlated with Pgrmc1 expression (Ukena et al., 1998, Ukena et 
al., 1999, Sakamoto et al., 2004).  High levels of Pgrmc1 expression were detected in 
the ER of these neurons during times of elevated P4 production (Sakamoto et al., 2008).  
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P4 biosynthesis from Purkinje neurons is required for dendritic growth and 
synaptogenesis (Sakamoto et al., 2001), indicating that Pgrmc1 may be required for P4-
induced developmental processes. 
 Pgrmc1 expression in development is also elevated along the floor plate and 
notochord of developing murine brain, suggesting a role in axon guidance (Runko et al., 
1999).  Indeed, one of Pgrmc1’s early synonyms is ventral midline antigen (VEMA).  
Pgrmc1 expression shares a very close distribution pattern to molecules required for 
axon guidance at the midline in the developing spinal cord and optic chiasm (Ho et al., 
1994, Runko and Kaprielian, 2002).  More support for a role in development is 
provided by work on the C. Elegans ortholog of Pgrmc1, vem-1.  Animals treated with 
vem-1 siRNA and vem-1-null mutants are characterized by aberrant neuronal 
projections and midline neurons that fail to reach their ventral positions (Runko and 
Kaprielian, 2004).   Taken together, these findings on Pgrmc1’s role in axon guidance 
provide intriguing clues, but unequivocal evidence for this idea is lacking as research on 
this topic is very limited.    
In the adult rat brain, very little is known regarding the function of Pgrmc1.  
Localization studies lead to proposed roles of Pgrmc1 in water homeostasis and 
neuroendocrine functions (Krebs et al., 2000, Meffre et al., 2005).  The actual cellular 
role of Pgrmc1 is much less clear, but one possibility is a role in P4 signaling, as 
suggested by findings in ovarian cells.  For example, Pgrmc1 mediates the anti-
apoptotic effects of P4 in granulosa cells (Peluso et al., 2001).  These rapid P4 actions 
require that Pgrmc1 interact with a binding partner, Serpine1 mRNA binding protein 1 
(Peluso et al., 2005), but whether this interaction persists in neural cells is not known.   
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The current state of research on Pgrmc1’s role in the brain poses many 
questions.  Despite multiple links between P4 and Pgrmc1, it is not known if Pgrmc1 is 
required to mediate P4 actions in the brain.  Furthermore, the neuroanatomical 
localization of Pgrmc1 in the brain is largely unknown, and the factors that induce 
Pgrmc1 expression have not yet been identified.  The expression of Pgrmc1 has only 
been reported in vasopressinergic (Meffre et al., 2005) and Purkinje cells (Sakamoto et 
al., 2004), neural phenotypes confined to distinct brain regions.  To begin to address 
these questions, the following chapters report my research conducted to test the 
hypothesis that Pgrmc1 has important functions in the brain. 
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CHAPTER 2 
DISTRIBUTION OF mRNAS ENCODING CLASSICAL PROGESTIN 
RECEPTOR, PROGESTERONE MEMBRANE COMPONENTS 1 AND 2, 
SERPINE MRNA BINDING PROTEIN 1, AND PROGESTIN AND ADIPOQ 
RECEPTOR FAMILY MEMBERS 7 AND 8 IN RAT FOREBRAIN 
 
2.1 Abstract 
Several lines of evidence suggest the existence of multiple progestin receptors 
that may account for rapid and delayed effects of progesterone in the central nervous 
system.  The delayed effects have been long attributed to activation of the classical 
progestin receptor (Pgr).  Recent studies have discovered novel progestin signaling 
molecules that may be responsible for rapid effects, including progesterone receptor 
membrane component 1 (Pgrmc1), Pgrmc2, progestin and adipoQ receptor 7 (Paqr7) 
and Paqr8.  The functions of these molecules have been investigated extensively in non-
neural, but not in neural tissues, partly because it is unclear which are expressed in the 
brain and where they are expressed.  To address these issues, we compared the 
distributions of mRNAs encoding Pgr, Pgrmc1, Pgrmc2, Paqr7 and Paqr8 using in situ 
hybridization (ISH) with radiolabeled oligodeoxynucleotidyl probes in forebrain tissues 
of estradiol-treated female rats.  We also examined the distribution of serpine mRNA 
binding protein 1 (Serbp1), a putative binding partner of Pgrmc1.  Analysis of adjacent 
brain sections showed that the highest expression of mRNAs encoding Pgr, Pgrmc1, 
Pgrmc2 and Serbp1 was detected in several hypothalamic nuclei important for female 
reproduction.  In contrast, expression patterns of Paqr7 and Paqr8 were low and 
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homogeneous in the hypothalamus, and more abundant in thalamic nuclei.  The 
neuroanatomical distributions of these putative progestin signaling molecules suggest 
that Pgrmc1 and Pgrmc2 may play a role in neuroendocrine functions while Paqr7 and 
Paqr8 are more likely to regulate sensory and cognitive functions.   
2.2 Introduction 
Progesterone (P4) is widely recognized for its ability to regulate neural functions 
related to reproduction, but it also affects diverse processes such as cognition and 
neurogenesis (Berman et al., 1997, Giachino et al., 2003).  The traditional tenet of P4 
action is that it binds the cognate progestin receptor (Pgr), and functions as a ligand-
activated transcription factor to regulate gene expression.  However, rapid non-genomic 
effects have also been reported (Meyerson, 1972, Parsons et al., 1980, Mani et al., 
1994b), and P4 can act in the absence of Pgr (Frye et al., 2006).  These data support the 
emerging concept that P4 actions in the brain may be through the classical Pgr and also 
through non-classical mechanisms. 
Current research suggests that there are several possible candidates for 
mediating the non-classical effects of P4.  One such protein is progesterone receptor 
membrane component 1 (Pgrmc1), but it does not appear to function as a traditional 
receptor because it requires a binding partner known as serpine mRNA binding protein 
1 (Serbp1) (Peluso et al., 2005, 2006).  Moreover, the structure of Pgrmc1 does not 
share homology with either classical steroid receptors or G-coupled protein receptors 
(Mifsud and Bateman, 2002).  Nonetheless, Pgrmc1 mediates several important Pgr-
independent effects.  For example, P4 acts through Pgrmc1 to activate phosphoinositide-
dependent protein kinase 1 and phosphorylate Akt (Hand and Craven, 2003).  In the 
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ovary, Pgrmc1 and Serbp1 form a receptor complex required for the antiapoptotic 
effects of P4 in granulosa cells (Peluso et al., 2006, Zhang et al., 2008).  Pgrmc2 is a 
closely related isoform of Pgrmc1, differing mainly in its N-terminus, but there is 
virtually no information regarding Pgrmc2 function (Falkenstein et al., 1999, Peluso et 
al., 2005).  Pgrmc1 has been localized to several brain regions (Krebs et al., 2000, 
Sakamoto et al., 2004, Meffre et al., 2005), but no studies have systematically mapped 
its distribution and the role of this protein in the brain remains unknown.  Likewise, no 
studies have mapped neural expression of Serbp1 or Pgrmc2.  Despite these limitations, 
several lines of evidence indicate that Pgrmc1/Serbp1, and possibly Pgrmc2, may be 
important for non-classical P4 actions in the brain. 
Two other candidates for mediating the non-genomic effects of P4 are progestin 
and adipoQ receptor 7 (Paqr7) and Paqr8.  These are G-protein coupled receptors first 
discovered in spotted sea trout, and subsequently in mammalian tissues (Zhu et al., 
2003a, Zhu et al., 2003b).  Although activation of these receptors by P4 regulates cAMP 
levels and MAPK activity in fish (Hanna et al., 2006), there is some debate about 
whether they function as bona fide P4 receptors in mammals (Fernandes et al., 2008).  
Recent reports detected Paqr7 and Paqr8 mRNAs in hypothalamic tissue of mice, but 
the exact anatomical localization is unknown (Sleiter et al., 2009).  Collectively, these 
findings raise the possibility that Paqr7 and Paqr8 also mediate P4 neural actions. 
Although there is abundant evidence that these signaling molecules participate 
in P4 signaling, it is unclear which are important in the nervous system.  Moreover, 
while many neural functions are modulated by P4, there is little information about which 
functions require Pgr, non-nuclear receptors or both.  One obstacle to resolving this 
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question is that neither the classical Pgr nor any of the non-classical P4 receptor 
candidates have been systematically mapped in the brain.  To address this issue, we 
used in situ hybridization histochemistry (ISHH) to map the expression of mRNAs 
encoding Pgr, Pgrmc1, Pgrmc2, Serbp1, Paqr7 and Paqr8.  In these studies, we used 
female rats because of the important role P4 plays in regulation of female-specific 
physiological functions.     
2.3 Materials and Methods 
2.3.1 Animals and Tissue Preparation 
 All protocols were approved by the Institutional Animal Care and Use 
Committee of the University of Massachusetts and all animals were housed in 
accordance with the National Institutes of Health Guidelines for the Care and Use of 
Laboratory Animals.  Six adult female Sprague-Dawley rats (225-250 g; approximately 
95 days of age; Harlan Sprague-Dawley, Madison WI) were individually housed in the 
Animal Care Facility on a 14:10 light:dark cycle with food and water provided ad 
libitum.  To achieve a similar hormonal milieu among rats, we ovariectomized them and 
implanted two Silastic capsules containing E2 (150 µg/ml 17β-estradiol in sesame oil) a 
week later as described previously (Petersen and LaFlamme, 1997).  Twenty-four hours 
later, we collected brains and rapidly froze and stored them at -80 °C until they were 
cryosectioned (Leica CM3000, Nussloch, Germany). 
For three animals, 14-µm coronal forebrain sections were obtained and thaw-
mounted onto gelatin-coated slides and stored at -80 °C until ISHH was performed.  
The remaining three animals were used for RNA isolation in validation studies 
described below. 
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2.3.2 Probe Preparation 
 In these studies, we used oligodeoxynucleotidyl probes of the same length and 
specific activity.  Antisense oligodeoxynucleotide sequences used for end-tailing are 
provided in Table 2.6.1.  Both sense and antisense sequences were produced by an 
automated DNA synthesizer and purified by reverse-phase HPLC by Integrated DNA 
Technologies (Coralville, IA).  Oligodeoxynucleotides were 3’-end labeled with [α33P]-
dATP (PerkinElmer, Waltham, MA) using terminal deoxynucleotidyl transferase 
(Roche, Indianapolis, IN) as described previously (Petersen et al., 1989).  Incubation 
was halted by addition of TE (10mM Tris-HCL; pH 8.0, 1 mM EDTA), and the probe 
was purified by phenol-chloroform extraction and ethanol precipitation.  The resulting 
pellet was washed with 70% ethanol and resuspended in 25 µl TE. 
2.3.3 ISHH 
The distribution pattern for each mRNA was determined in separate ISHH runs, 
and tissue sections were prehybridized as previously described (Ottem et al., 2004).  
Radioisotopic probes (0.5 x 106 cpm) were applied directly to brain tissue in 20 µl 
hybridization buffer.  This buffer contained 4XSSC (1XSSC = 0.15 M NaCl/0.015 M 
sodium citrate, pH 7.2), 50% (v/v) formamide, 10% (w/v) dextran sulfate, 250 µg/ml 
yeast tRNA, 1X Denhardt's solution, 500 µg/ml heparin sodium salt, 0.1% sodium 
pyrophosphate and 0.05 M dithiothreitol added freshly before use.  Sections were 
covered with glass coverslips and hybridized overnight at 37 °C in humidified plastic 
boxes.  Slides were removed from 37 °C and allowed to cool, and coverslips were 
floated off in 1XSSC.  They were washed four times for 15 minutes each in 2XSSC-
50% formamide solution at 40 °C, followed by four washes, 15 minutes each, in 
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1XSSC.  Finally, slides were rinsed in water and briefly dehydrated in 70% ethanol.  
The slides were air-dried and apposed to Kodak BioMax MR film (Rochester, NY) for 
signal detection.  In order to acquire optimum signal, autoradiograms were developed at 
1, 3 and 6 weeks by an X-ray film processor and images were acquired using BioQuant 
Imaging Software (Bio-Quant Inc, Nashville, TN,) and a CCD videocamera (QImaging 
QICAM FAST color).   
2.3.4 Validation of probe specificity 
To determine the specificity of the hybridization signal, sense strand probes to 
each target of interest were hybridized to representative sections.  To verify specificity 
of each antisense probe, subsets of adjacent slides were treated with RNAse A solution 
(100 µg/ml RNAse A in 0.5 M NaCl, 0.05 M EDTA and 0.01 M Tris-HCl) for one hour 
at 37 °C following prehybridization.  An additional set of slides was used for Nissl 
staining in order to provide reference material for identification of specific brain 
regions.   
Regardless of exposure time, Paqr7 and Paqr8 antisense probes produced diffuse 
and homogeneous signal, therefore multiple probes (Table 2.6.2) were used for each 
gene to verify signal specificity.  To ensure specificity in regions that displayed low 
ISHH signal for Paqr7, quantitative polymerase chain reaction (QPCR) was performed 
using cDNA derived from RNA of the diagonal band of Broca and striatum, regions 
with two different signal intensities.  RNA was isolated from tissue punches using the 
RNeasy Lipid Tissue Kit (Qiagen, Valencia, CA) and reverse transcribed into cDNA 
using Quantitect Reverse Transcription Kit (Qiagen) and manufacturer’s protocol.  
Reactions were performed in a Stratagene Mx3000P instrument programmed as 
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follows: 95 °C, 10 min, and 40 cycles of 95 °C for 15 sec and 60 °C for 60 sec.  
Reactions contained reagents from QuantiTect SYBR Green Kit and manufacturer’s 
protocols were used (Roche Diagnostics, Indianapolis, IN).  Specific primer sets were 
obtained from Integrated DNA Technologies, and the forward and reverse primers used 
to detect Paqr7 mRNA were 5’-TGCACCGCATCATAGTGTC-3’ and   
5’-GATAGTCCAGCGTCACAGC-3’.  Resulting cycle thresholds were normalized 
using forward and reverse primers for beta-actin: 5’-GGGAAATCGTGCGTGACATT-
3’ and 5’- GCGGCAGTGGCCATCTC-3’.  Samples with no cDNA were used as 
negative controls.  Products were resolved using 2% agarose gel electrophoresis.  
2.3.5 Data Analysis 
 Neuroanatomic mapping of Pgrmc1, Pgrmc2, Paqr7, Paqr8, Serbp1 and Pgr was 
performed with the aid of a rat brain atlas (Swanson, 1998) and Nissl-stained adjacent 
sections.  Relative levels of mRNA were determined by optical densitometric 
measurements of the autoradiographic signals across different brain regions.  Results of 
this semiquantitative ISHH were obtained by digitizing all autoradiographic images and 
four ranges of density of labeling were used to determine relative intensities across 
brain regions and across probes.  Signal strength intensity was determined using 
arbitrary optical density units and denoted by – (background; 0-51), + (low; 52-102), ++ 
(moderate; 103-153), +++ (154-204), and ++++ (highest signal intensity; 205-255).  
Digitized images were imported into Adobe Photoshop 8.0 CS (Adobe Systems Inc., 
San Jose CA) and all figures were cropped to the same size for display.   
 For QPCR studies, relative levels of Paqr7 mRNA were analyzed using the 2-
∆∆Ct method (Livak and Schmittgen, 2001). 
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2.4 Results 
2.4.1 Probe Specificity 
We verified the specificity of the probes used in these studies in several ways.  
All four oligodeoxynucleotidyl probes for each target produced the same labeling 
pattern.  In addition, neither sense strand controls nor RNAse A-treated sections showed 
specific signal with the exception of the sense probe for Paqr7.  Although Paqr7 sense 
strand control probes showed signal above background, the signal for antisense probes 
was abolished by tissue pretreatment with RNAse A (Fig. 2.7.1, D3).  Moreover, QPCR 
detected a single band of expected size using primers to Paqr7.  Consistent with our 
ISHH findings, QPCR detected higher mRNA levels in the diagonal band of Broca than 
in the striatum (data not shown).   
2.4.2 Distribution of Pgrmc1, Serbp1, Pgrmc2, Paqr7, Paqr8 and Pgr mRNAs 
The neuroanatomical distributions of mRNAs encoding Pgrmc1, Serbp1, 
Pgrmc2, Paqr7, Paqr8 and Pgr are presented in Table 2.6.3.  The distributions of 
mRNAs encoding Pgrmc1, Pgrmc2 and Serbp1 overlapped extensively throughout the 
brain, and some of these regions displayed high levels of the classical Pgr, most notably 
in ventral structures.  Paqr7 and Paqr8 mRNAs were not highly expressed in these 
structures, but showed expression patterns similar to one another.  Unlike signals for 
probes to Pgrmc1, Pgrmc2, Serbp1 and Pgr, signals for Paqr7 and Paqr8 probes were 
characterized by diffuse labeling found predominantly in the thalamus.   
2.4.3 Diencephalon 
In the rostral diencephalon, high signal intensities for Pgrmc1 mRNA were 
detected in several olfactory nuclei as indicated in Fig. 2.7.1, A1.  We found moderate 
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signal for mRNAs encoding Pgrmc1, Paqr7 and Paqr8 in the diagonal band of Broca 
(Fig. 2.7.1; A1, D1 and E1, respectively).  In the preoptic area (POA), the AVPV 
nucleus displayed very high levels of mRNAs encoding Pgrmc1 and Pgr (Fig. 2.7.2, A1 
and F1).  Serbp1 and Pgrmc2 also showed elevated signal intensities in this nucleus 
(Fig. 2.7.2, B1 and C1).  Although Paqr7 and Paqr8 mRNAs were found in the POA, 
clearly defined signal within the AVPV was not apparent (Fig. 2.7.2, D1 and E3).  The 
bed nucleus of the stria terminalis contained dense labeling for Pgrmc1, Serbp1 and Pgr 
(Fig. 2.7.2, A2, B2 and F2).  Moderate levels of mRNAs encoding Pgrmc1 and Paqr8 
were found in the rostral portion of the lateral septal nucleus (Fig. 2.7.2, A1 and E1).       
The paraventricular nucleus (PVN) and supraoptic nucleus (SON) showed 
abundant labeling for Pgrmc1, Serbp1, and Pgrmc2 (Fig. 2.7.2, A3, B3 and C3).  High 
signal for probes encoding these mRNAs was also detected in the zona incerta, 
ventromedial nucleus (VMH) and arcuate nucleus (Arc), a finding consistent with the 
distribution of Pgr (Fig. 2.7.3, A1, B1, C1 and F1).  The reunions nucleus of the 
thalamus showed moderate levels of mRNAs encoding Pgrmc1, Serbp1, Pgrmc2 and 
Pgr mRNAs (Fig. 2.7.3, A1, B1, C1 and F1).  In contrast, probes for these mRNAs 
showed low levels of signal intensity in the ventromedial thalamic nuclei while those 
encoding Paqr7 and Paqr8 were somewhat prominent (Fig. 2.7.3, column 1).  The 
anterodorsal and anteroventral thalamic nuclei displayed similarly elevated levels of 
Serbp1 and Paqr8 gene expression (Fig. 2.7.3, B1 and E1).    
2.4.4 Telencephalon 
 The hippocampus showed intense hybridization signals for Pgrmc1, Serbp1, 
Pgrmc2 and Pgr probes as shown in Fig. 2.7.3, columns 1 and 2.  Within this region, 
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signal intensities were highest in the CA2 and CA3 for all four mRNAs.  In the dentate 
gyrus, stronger signal was detected for mRNAs encoding Pgrmc1, Serbp1 and Pgrmc2 
(Fig. 2.7.3, A2, B2 and C2) than for those encoding Pgr (Fig. 2.7.3, F2).  Paqr8 
displayed low to moderate signal intensity within the hippocampus (Fig. 2.7.3, E2).  In 
contrast, mRNAs encoding Paqr7 were undetectable in CA1, CA2, CA3 and dentate 
gyrus (Fig. 2.7.3, D1 and D2).   
 In the cortex, moderate levels of mRNAs were observed for Pgrmc1, Serbp1, 
Pgrmc2, Paqr8 and Pgr as shown in column 2 of Fig. 2.7.1.  High signal intensity was 
detected in cortical regions for Pgrmc1, Serbp1 and Pgr mRNA (Fig. 2.7.3, row A, B 
and F).  The medial amygdala showed moderate expression of Pgrmc1, Serbp1, Pgrmc2 
and Pgr (Fig. 2.7.3, columns 1 and 2).  Alternatively, Paqr7 and Paqr8 signals in the 
amygdala were low overall (Fig. 2.7.3, D2 and E2)      
 The highest levels of mRNAs encoding Pgrmc1, Serbp1 and Pgr in the caudal 
forebrain were detected in the periaqueductal gray (PAG) (Fig. 2.7.3, A3, B3 and F3).  
Pgrmc2 mRNA levels were moderately high within this region (Fig. 2.7.3, C3), but 
Paqr7 and Paqr8 mRNAs were very low (Fig. 2.7.3, D3 and E3).  Interestingly, Paqr8 
mRNA levels were highest in the nucleus of the oculomotor tract (Fig. 2. 7.3, E3).  
Finally, within the substantia nigra and interpeduncular nucleus, we detected 
moderately high levels of mRNAs encoding Pgrmc1, Serbp1 and Pgr (Fig. 2.7.3, A3, 
B3 and F3).  
2.5 Discussion 
 Collectively, these neuroanatomical mapping data provide important clues as to 
functions of putative progestin signaling molecules.  The high levels of Pgrmc1 and 
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Pgrmc2 mRNAs within virtually all hypothalamic nuclei suggest that these molecules 
are likely candidates for mediating rapid neuroendocrine effects.  Moreover, signals for 
Pgrmc1 and Pgrmc2 mRNAs were strongest in regions that also contained Pgr and 
regulate reproductive functions, consistent with the idea that these functions require 
both rapid and delayed actions of P4.  Pgrmc1 and Serbp1 mRNAs displayed strongly 
overlapping distribution patterns supporting the idea that these molecules interact to 
form a functional receptor (Peluso et al., 2004).  Our data indicate that Paqr7 and Paqr8 
may be important in sensory relay systems and other less well understood P4 functions 
regulated by thalamic and cortical brain regions.  Our findings suggest that P4 may act 
through a number of signaling molecules to influence a much broader array of 
physiological effects than previously recognized.   
The specific neural mechanisms underlying the role of Pgrmc1 have not yet 
been delineated, but the distinctive and overlapping patterns of Pgrmc1 and Serbp1 
mRNAs suggest that these molecules may interact in neurons as they do in other cells.  
In granulosa cells, P4 activation of the Pgrmc1/Serbp1 complex stimulates 
phosphorylation cascades through activation of protein kinase G (Peluso et al., 2007).  
Protein kinase G can activate additional kinases such as phosphoinositide 3-kinase, 
resulting in phosphorylation of Akt (Kandel and Hay, 1999, Brazil and Hemmings, 
2001).  The rapid phosphorylation of Akt in response to P4 has been observed in cells 
from cortex and hippocampus (Singh, 2001, Hwang et al., 2009), and our study shows 
that both brain regions contain Pgrmc1 and Serbp1.  Taken together, these observations 
suggest that phosphorylation events initiated by P4 may involve the Pgrmc1/Serbp1 
complex. 
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Brain regions rich in Pgrmc1 and Serbp1, as well as Pgrmc2 and Pgr, include the 
AVPV, medial preoptic (MPN), Arc and suprachiasmatic nuclei (SCN).  These findings 
are in agreement with previous immunocytochemical and ISHH studies of Pgr and 
Pgrmc1 (Parsons et al., 1982, Krebs et al., 2000, Curran-Rauhut and Petersen, 2002, 
Meffre et al., 2005).  Each of these nuclei contribute to the timing and magnitude of the 
preovulatory luteinizing hormone (LH) surge, a process in which P4 exerts rapid and 
delayed effects.  For example, estrogen induction of the LH surge requires Pgr 
expression in the AVPV/MPN (Chappell and Levine, 2000), and P4 rapidly advances 
and augments the LH surge in estradiol-primed female rats (Krey et al., 1973, DePaolo 
and Barraclough, 1979, Levine and Ramirez, 1980).  Our findings that the AVPV/MPN 
displayed high levels of Pgrmc1, Serbp1 and Pgrmc2 support the idea that these 
signaling molecules mediate rapid P4 effects in the LH surge mechanism.  P4 also 
rapidly represses basal LH levels, and this action may involve the Arc (Banks and 
Freeman, 1978, Goodman et al., 1981, Richter et al., 2005), where Pgrmc1, Pgrmc2 and 
Serbp1 mRNA levels were also high.  Finally, levels of these mRNAs were elevated in 
the SCN, and while not directly linked to reproduction, this nucleus sends projections to 
the AVPV and is critical for the temporal regulation of the LH surge (Paxinos and 
Watson, 1982, Watts and Swanson, 1987, de la Iglesia et al., 1995).  Although the rapid 
effects of P4 on LH surge release may be mediated by membrane-associated Pgr 
(Hammes and Levin, 2007), the current observations suggest that Pgrmc1, Pgrmc2 and 
Serbp1 may also play a role.  
We found high levels of mRNAs encoding Pgrmc1, Pgrmc2, Serbp1 and Pgr in 
the VMH and in PAG, brain regions important for P4-dependent female sex behaviors 
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(Pfaff and Sakuma, 1979, Rubin and Barfield, 1983).  This confirms a previous report 
of Pgrmc1 in the VMH (Krebs et al., 2000).  Rat copulatory behavior requires activation 
of the Pgr within the VMH (Pollio et al., 1993, Ogawa et al., 1994), a nucleus that sends 
projections to many brain regions including the PAG (Saper et al., 1976).  In the PAG, 
P4 rapidly elicits female sexual receptivity (Gorski, 1974, Wise et al., 1981), an effect 
originally attributed to Pgr expression in this region.  However, work in Pgr-null mice 
shows that sexual receptivity can be rapidly induced by midbrain injection of P4, 
indicating a role for other signaling mechanisms (Beyer et al., 1988, Frye and Vongher, 
1999).  One such mechanism involves P4 metabolism to allopregnanolone, a molecule 
that induces feminine sex behaviors when injected into the midbrain (Beyer et al., 1988, 
Pfaff et al., 1994).  The present work suggests another possibility, namely that Pgrmc1 
contributes to elicitation of sexual receptivity by mediating rapid P4 signaling through 
phosphorylation events as described above.  Alternatively, Pgrmc1 may influence sex 
behavior through actions on neurosteroid production in the midbrain, a process that may 
be required for feminine sex behavior (Akesson et al., 1988, Frye et al., 2007).  
Consistent with this idea, Pgrmc1 interacts with key regulators of cholesterol 
homeostasis (Suchanek et al., 2005) and enhances steroidogenesis in diverse cell types 
(Laird et al., 1988, Min et al., 2004). 
The present study identified high levels of Pgrmc1, Pgrmc2 and Serbp1 mRNAs 
in regions not directly linked to reproduction.  For example, we confirmed previous 
findings that Pgrmc1 is expressed in the PVN and SON (Krebs et al., 2000, Meffre et 
al., 2005), and extend these findings to show that Pgrmc2 and Serbp1 mRNAs were also 
found in these nuclei.  The physiological significance of these findings are unclear, but 
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Meffre et al. found that Pgrmc1 protein was expressed specifically within 
vasopressinergic neurons of the PVN and SON, suggesting that Pgrmc1 may play a role 
in regulation of water and ion homeostasis (Meffre et al., 2005).  We also found 
Pgrmc1, Pgrmc2 and Serbp1 mRNAs in CA1, CA2, CA3 and dentate gyrus.  These 
findings may be relevant to the observation that P4 enhances hippocampal-dependent 
cognitive performance (Hoshina et al., 1994, Sandstrom and Williams, 2001).  Our data 
also compliment previous findings of Pgrmc1 and Pgrmc2 mRNAs in neuroprogenitor 
cells derived from adult hippocampus (Liu et al., 2009).  In these cells, the authors 
showed that P4 induces neurogenesis through Pgrmc1-dependent phosphorylation 
cascades that do not require Pgr.  These findings suggest that non-genomic signaling 
events involving Pgrmc1, and possibly Pgrmc2 and Serbp1, underlie P4 actions in 
diverse neural functions.   
Neither Paqr7 nor Paqr8 genes were strongly expressed in neural regions that 
control gonadotropin release and contain abundant Pgrmc1 mRNA.  This was somewhat 
surprising because these genes are colocalized in other parts of the reproductive system.  
For example, Paqr7, Paqr8 and Pgrmc1 have been detected in cells of the ovary, uterus, 
and placenta in rats, sheep, and humans (Zhu et al., 2003a, Cai and Stocco, 2005, Peluso 
et al., 2006, Zhang et al., 2008, Ashley et al., 2009).  Moreover, in the rat corpus 
luteum, the expression of each of these genes changes during pregnancy, and the 
patterns of change for Paqr7 and Pgrmc1 expression are strikingly similar (Cai and 
Stocco, 2005).  In contrast to Pgrmc1, neither Paqr7 nor Paqr8 mRNA levels are found 
at levels much above background in AVPV/MPN.  However, the AVPV provides 
afferent projections to GnRH neurons and results of recent studies show that Paqr7 and 
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Paqr8 are functional in GT1-7 immortalized GnRH neurons (Sleiter et al., 2009).  Thus, 
it is possible that Paqr7 and Paqr8 impact the neural control of reproduction, but 
through GnRH neurons scattered in the rostral preoptic area that also receive signals 
from Pgrmc1-containing neurons of the AVPV. 
Though we did not find strong evidence for Paqr7 or Paqr8 gene expression in 
neuroendocrine nuclei, their expression was high in thalamic and cortical brain regions 
suggesting that these may participate in less well-studied actions of P4.  The thalamus is 
known primarily as a sensory relay system but few studies have examined P4 actions 
within this brain region.  However, P4 binding occurs in the lateral septal nucleus of the 
thalamus (Shughrue et al., 1992) where we found high levels of mRNA encoding Paqr8.  
This is important because present and previous studies have found that the Pgr is absent 
in this brain region (Parsons et al., 1982).  P4 binding within the lateral septum 
decreases anxiety and depression-like behaviors (Pesold and Treit, 1992, Estrada-
Camarena et al., 2002), and these effects have been presumed to be mediated by P4 
metabolites acting on GABAA receptors (Majewska et al., 1986).  Similarly, GABAA 
receptors are implicated in the neuroprotective effects of P4 in the cortex, a region in 
which we observed high levels of Paqr7, Paqr8 and Pgr mRNAs.  In light of the present 
findings, it is also possible that Paqr8 mediates P4 actions in the lateral septum and 
cortex.  This idea is supported by findings that in the cortex, maximal neuroprotective 
effects of P4 require activation of MAPK and phosphoinositide 3-kinase pathways 
(Kaur et al., 2007), suggesting a role for membrane-initiated P4 signaling, possibly 
involving Paqr7 and Paqr8.     
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In summary, we found that genes encoding Pgrmc1, Serbp1, Pgrmc2 and Pgr, 
but not Paqr7 and Paqr8, were highly expressed in many preoptic and hypothalamic 
nuclei and their projection sites.  In contrast, Paqr7 and Paqr8 mRNA levels were most 
robust in thalamic nuclei and cortex.  In view of these neuroanatomical findings, it is 
tempting to speculate that Pgrmc1 and Pgrmc2 control neuroendocrine functions, while 
Paqr7 and Paqr8 regulate affect and cognition.  Additionally, the extensive overlap of 
Pgrmc1, Pgrmc2 and the classical Pgr mRNAs raise the intriguing possibility that these 
molecules interact within the same cells to regulate rapid and delayed P4 effects in the 
brain.  However, there were some regions in which Pgrmc1 and Pgrmc2 may exert 
effects independently of the Pgr.  Together, these data provide anatomical information 
that will be important for determining the functional roles of these novel P4 signaling 
molecules.   
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2.6.1: Sequences for Oligodeoxynucleotidyl Probes Used in ISHH Studies 
NCBI Gene 
and Accession # Oligodeoxynucleotide Sequences 5’- 3’ 
AS to 
bases 
Pgrmc1 
NM_021766 TGTAGTTCCAACCCAATTACCAGGTGTGTGAGAGTTACTGTGTGTGG 
1354- 
1305 
Pgrmc2 
NM_001008374 CAAAGTTCAGTCCTGTTTACTGTGATCCTTGGTGTCCTCCTCGTCTGT 
667- 
619 
Serbp1 
NM_145086 AAGGAACCAGTGTTGTATTATGGCATCCAGTTAGGCCAGAGCGGGGAA 
1274- 
1227 
Paqr7 
NM_001034081 ATAGTCCAGCGTCACAGCTTCTAGCTGGGCTAAAGTGCACAGCACC 
888- 
843 
Paqr8 
NM_001014099 
GCCAGCCCCGCTGGTACCACTTGACAGATCTTCCGCATAACTGGATA 1112- 1065 
Pgr 
NM_022847 CACATGGTAAGGCACAGCGAGTAGAATGACAACTCCTTCATCCTCTG 
2375- 
2328 
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 2.6.2: Oligodeoxynucleotidyl Sequences for ISHH Validation Studies 
NCBI Gene Name 
and Accession # Oligodeoxynucleotide sequences 5’- 3’ 
Antisense       
to bases: 
Paqr7 
NM_001034081 
GGTACACGGCCACACCCACATAGTCCAAGAAGAAGAAGCTGTAATGC 445-398 
GGGGCCAACGGGCGTGCAGAGGCTTATAGATGGCTCCCCGAGCCTGA 934-887 
CAGGCTGGACAGCAGGTGGCTGAACTTCTGGGCTACTGCCATCGCCAT 48-1 
Paqr8 
NM_001014099 
TTCTGGGACGGTGCATGGCATCTTGGGAAGCCCTTCTTCCAGAATCTT 570-523 
GAGCCAGGCCGGTGGTGAGTTTGAGGCCAGCCTGCTCTATAGAGTGAG 238-191 
GTGAGCCAAGGCGCTGCCATACTGGTAGACACTGACCCCGACGTAGTC 486-439 
 
 
 
2.6.3: Localization and Abundance of mRNA encoding Pgr, Pgrmc1,   
 Serbp1, Pgrmc2, Paqr7 and Paqr8 in Female Rat Forebrain1 
 
 42 
 
 
 43 
 
2.7.1 Photomicrographs of ISHH 
 
Figure 2.7.1: Photomicrographs of film autoradiograms of hybridized rat brain 
sections to 33P-labeled oligodeoxynucleotidyl probes for (A) Pgrmc1, (B) Serbp1, 
(C) Pgrmc2, (D) Paqr7, (E) Paqr8 and (F) Pgr.  For Pgrmc1, Serbp1, Pgrmc2, 
Paqr8 and Pgr, the sense (S) strand probe is shown in the third image of each 
series.  For Paqr7, the section was hybridized to the antisense probe and then 
treated with RNAse A.  Scale bar = 200 µm. 
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 2.7.2 Photomicrographs of ISHH 
 
 
Figure 2.7.2: Rostral to caudal arrangement of photomicrographs of film 
autoradiograms of hybridized rat forebrain sections to 33P-labeled 
oligodeoxynucleotidyl probes for (A) Pgrmc1, (B) Serbp1, (C) Pgrmc2, (D) Paqr7, 
(E) Paqr8 and (F) Pgr.  Scale bar = 200 µm. 
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2.7.3 Photomicrographs of ISHH 
 
Figure 2.7.3: Rostral to caudal arrangement of photomicrographs of film 
autoradiograms of hybridized rat forebrain sections to 33P-labeled 
oligodeoxynucleotidyl probes for (A) Pgrmc1, (B) Serbp1, (C) Pgrmc2, (D) Paqr7, 
(E) Paqr8 and (F) Pgr.  Scale bar = 200 µm. 
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CHAPTER 3 
17Β-ESTRADIOL AND PROGESTERONE REGULATE  
PROGESTIN SIGNALING MOLECULES IN THE ANTEROVENTRAL 
PERIVENTRICULAR NUCLEUS, VENTROMEDIAL NUCLEUS AND 
SEXUALLY DIMORPHIC NUCLEUS OF THE PREOPTIC AREA IN RATS 
3.1 Abstract 
Recent work identified novel progestin signaling molecules, including 
progesterone receptor membrane component 1 (Pgrmc1), Pgrmc2, serpine mRNA 
binding protein 1 (Serbp1), progestin and adiponectin receptors 7 (Paqr7) and Paqr8.  
These molecules mediate rapid progesterone (P4) effects in non-neural tissue and we 
recently mapped their expression in the brain.  Many rapid effects of P4 require 17β-
estradiol (E2) and P4 priming; therefore, we examined the effects of ovarian hormones 
on the expression of these non-classical progestin signaling molecules.  We focused 
specifically on the anteroventral periventricular nucleus (AVPV), the sexually 
dimorphic nucleus of the preoptic area (SDN-POA) and the ventrolateral portion of the 
ventromedial nucleus (VMNvl).  These brain nuclei are important for female 
reproduction.  Ovariectomized adult female rats were implanted with capsules 
containing sesame oil or E2, and injected 48 hours later with sesame oil or P4.  Brains 
were collected eight hours later and RNA was isolated from the AVPV, SDN-POA and 
VMNvl.  We assessed the effects of ovarian hormones on mRNA levels using 
quantitative polymerase chain reaction (QPCR).  In the AVPV, Serbp1 mRNA levels 
were increased by P4 in the presence of E2, and Paqr8 was downregulated by P4 alone.  
In the SDN-POA, combined E2 and P4 increased Pgrmc1 and Serbp1 mRNA levels, and 
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E2 alone increased Paqr8 mRNA levels.  Finally, in the VMNvl, P4 increased mRNA 
levels encoding Pgrmc1, Pgrmc2 and Serbp1, and the combination of E2 and P4 
increased Pgrmc1 and Serbp1 mRNA levels.  Paqr7 was not regulated by E2 or P4 in any 
brain region examined.  In summary, we showed that ovarian hormones regulate novel 
progestin signaling molecules in brain regions important for the neuroendocrine control 
of reproduction.  
3.2 Introduction 
P4 signaling in the female brain regulates several facets of reproduction 
including the neural control of ovulation and the expression of feminine sex behaviors.  
The molecular mechanisms underlying these P4 actions have been primarily attributed 
to activation of the progestin receptor (Pgr), a ligand-dependent transcription factor.  
This classical model of steroid hormone action has been revised to include rapid non-
genomic effects of Pgr activation on diverse signaling systems, such as MAPK and c-
Src pathways (Richer et al., 1998, Boonyaratanakornkit et al., 2001).  However, this 
model may still be incomplete because many cells that lack Pgr retain rapid P4-elicited 
responses (Ehring et al., 1998, Bar et al., 2000, Frye et al., 2006).  These findings may 
be explained by recent discoveries of novel progestin signaling molecules that mediate 
diverse responses to P4 in non-neural tissues (Falkenstein et al., 1999, Zhu et al., 2003b, 
Peluso et al., 2004).  
We recently mapped the expression of several of these progestin signaling 
molecules in the rat forebrain (Intlekofer and Petersen, 2010).  Genes encoding Pgrmc1, 
Pgrmc2 and Serbp1 were particularly abundant in neuroendocrine nuclei important for 
female reproduction.  We confirmed and extended findings on the distribution pattern of 
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Pgrmc1 (Krebs et al., 2000, Sakamoto et al., 2004, Meffre et al., 2005), and showed that 
the pattern overlaps closely with that of its binding partner, Serbp1, and Pgrmc1 
homologue, Pgrmc2.  Few studies have examined the role of these molecules in neural 
function, but Pgrmc1 and Serbp1 have been implicated in the rapid effects of P4 
observed in ovarian cells and sperm (Correia et al., 2007, Peluso et al., 2009).  While 
Pgrmc2 has not been studied in the context of rapid P4 signaling, it may mediate P4 
actions in the ovary (Nilsson et al., 2006).  Together these findings suggest that Pgrmc1, 
Pgrmc2 and Serbp1 may mediate non-classical P4 signaling in the brain as in other 
tissues.   
Other P4 signaling molecules include Paqr7  and Paqr8, G-protein-like receptors 
that bind P4 and regulate cAMP levels in several fish species (Zhu et al., 2003a, Zhu et 
al., 2003b, Hanna et al., 2006).  Although controversy surrounds their role in 
mammalian cells (Fernandes et al., 2008), mRNAs encoding Paqr7 and Paqr8 have been 
detected in mammalian reproductive tissues (Zhu et al., 2003a).  Our recent work 
showed that Paqr7 and Paqr8 gene expression is present in the hypothalamus (Intlekofer 
and Petersen, in press), though expression appears lower compared with that of Pgrmc1, 
Pgrmc2 and Serbp1.  Other evidence suggests that Paqr7 and Paqr8 mediate P4 
signaling and couple to inhibitory G proteins in immortalized gonadotropin-releasing 
hormone (GnRH) neurons (Sleiter et al., 2009).  Despite these significant advances, 
neither the regulation nor the functions of Paqr7 and Paqr8 in the brain are known. 
In the female rodent, many of the rapid P4 signaling events require 17β-estradiol 
(E2) activation of estrogen receptor 1 (Esr1) (Edwards, 2005).  This is partially due to 
E2 induction of Pgr (Kastner et al., 1990), a nuclear transcription factor that also 
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activates rapid intracellular kinase cascades (Leonhardt et al., 2003).  In regions of high 
Esr1 expression, such E2-induced effects result in greater P4-sensitivity.  For example, 
in the preoptic area (POA) and ventromedial nucleus (VMN) of the hypothalamus, E2 
exposure lowers cell signaling activation thresholds for P4, resulting in greater P4-
sensitivity (Balasubramanian et al., 2008).  In view of our recent findings that Pgrmc1, 
Pgrmc2, Serbp1, Paqr7 and Paqr8 are found in regions that contain Esr1 and Pgr, it is 
possible that E2 and/or P4 regulation of these molecules may be important in non-
classical P4 signaling.  This idea is supported by findings that Pgrmc1 expression is 
regulated by P4 in E2-primed rats (Krebs et al., 2000), uterine levels of Pgrmc2 
mRNA vary across the estrus cycle (Zhang et al., 2008) and Paqr7 and Paqr8 ovarian 
expression is regulated by E2 (Karteris et al., 2006).  It is unclear whether Pgrmc1 is 
regulated by steroids in brain regions other than the VMN, and no studies have tested 
the effects of ovarian steroids on Pgrmc2, Serbp1, Paqr7 and Paqr8 in the brain. 
To address these issues, we examined the effects of E2, P4 and the combination 
of E2 and P4 (E2+P4) on levels of mRNA encoding Pgrmc1, Pgrmc2, Serbp1, Paqr7 and 
Paqr8.  We focused specifically on the AVPV, the sexually dimorphic nucleus of the 
POA (SDN-POA) and the ventrolateral portion of the VMN (VMNvl). These nuclei 
have abundant expression of Esr1 and Pgr, are sexually dimorphic and are important for 
female reproduction (Dugger et al., 2007, Sakuma, 2009).  In addition, we recently 
found expression of Pgrmc1, Pgrmc2, Serbp1, Paqr7 and Paqr8 in these nuclei 
(Intlekofer and Petersen, in press). We now report that ovarian steroid hormones 
regulate these putative progestin signaling molecules, and do so in a region-specific 
manner. 
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3.3 Materials and Methods 
3.3.1 Animals 
All protocols and post-operative care were approved by the Institutional Animal 
Care and Use Committee of the University of Massachusetts, and animals were housed 
in accordance with the National Institutes of Health Guidelines for the Care and Use of 
Laboratory Animals.  Twenty-eight adult female Sprague-Dawley rats (200-250 g, 
Harlan, Madison, WI) were housed individually on a 14:10 light:dark cycle with food 
and water provided ad libitum.  Animals were anesthetized with isofluorane and 
bilateral ovariectomies were performed through very small (5-mm) flank incisions that 
minimized tissue trauma.  I observed animals for respiratory distress and bleeding for 6 
h postoperatively and examined again at 12, 24 and 48 h to ensure that they were freely 
moving and had no significant weight loss.  One week later (Day 0), animals were 
implanted s.c. with Silastic capsules (Dow Corning, Midland, MI; 1.57 mm, o.d., 3.8 
mm; 30 mm length) containing either sesame oil vehicle or E2 (150 µg/ml 17β-estradiol 
in sesame oil) as described previously (Petersen and LaFlamme, 1997).  At 0900 H on 
Day 2, animals were injected s.c. with either sesame oil vehicle or 50 mg P4.  Eight 
hours later, animals were anesthetized with CO2 and brains were rapidly frozen on 
powdered dry ice, wrapped in Parafilm (American Can Co., Greenwich, CT) and stored 
at -80 C. 
3.3.2 Tissue preparation 
 Coronal cryosections that contained the AVPV, SDN-POA and VMNvl were 
acquired using a Leica CM3000 cryostat (Nussloch, Germany).  These sections were 
taken from the rostral AVPV (bregma -0.02 mm), SDN-POA (bregma -0.4 mm) and 
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VMNvl (bregma -0.20 mm) (Swanson, 1998).  I obtained tissue punches from these 
sections using a 1.0-mm diameter Harris Uni-Core™ tissue needle (Ted Pella Inc., 
Redding, CA) from a single 300-µm section as illustrated in Fig. 3.7.1, and used this 
tissue for quantitative polymerase chain reaction (QPCR). 
3.3.3 RNA Isolation and QPCR 
RNA was isolated from tissue punches using the RNeasy kit (Qiagen, Valencia, 
CA) and reverse transcribed with the QuantiTect Reverse Transcription Kit (Qiagen), 
using manufacturer’s protocol.  QPCR was performed in a Stratagene Mx3000P 
thermocycler (Agilent Technologies, Wilmington, DE) programmed as follows: 95 C, 
10 min; 40 cycles of 95 C for 15 sec; and 60 C for 60 sec.  Reactions contained reagents 
from QuantiTect SYBR Green Kit, following manufacturer’s protocol (Roche 
Diagnostics, Indianapolis, IN).  Specific primer sets were obtained from Integrated 
DNA Technologies (Coralville, Iowa), and sequences are listed in Table 3.6.  The 
efficiency of each primer set was validated over a range of cDNA concentrations and 
samples with no cDNA were included as negative controls.  Primer specificity was 
verified using melting curve analyses and confirmation of a single fluorescence peak in 
each QPCR reaction.  Melting curve analyses were performed by heating samples to 95 
C for two min, 55 C for 15 sec, and recording fluorescence measurements during 
incremental increases of 0.5 C for 80 cycles.  Primer specificity was also validated 
using 2% agarose gel electrophoresis to verify single products following the QPCR 
reaction.  Fluorescence measurements were detected using MxPro™ QPCR analysis 
software (Agilent Technologies).  I verified that levels of mRNA encoding β-actin did 
not differ among treatments; therefore, I used it as an internal control (primers as 
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indicated in Table 3.6.1).  The ∆∆Ct method was used to analyze the data (Livak and 
Schmittgen, 2001). 
3.3.4 Statistics 
All data are expressed as mean ± SEM. Effects of E2, P4 and E2+P4 on mRNA 
levels were detected using a one-way ANOVA, followed by pair-wise comparisons 
using t-tests with Bonferroni correction . 
3.4 Results 
3.4.1 QPCR Reaction Specificity 
First, melting curve analyses verified a single peak of fluorescence, and the size 
of each product was confirmed by gel electrophoresis.  In addition, the PCR 
amplification efficiency calculated from the standard curve was between 96-100% for 
all primer sets used.  Consistent with our previous in situ hybridization findings 
(Intlekofer and Petersen, in press), QPCR verified that the genes of interest were 
expressed in the AVPV, SDN-POA and VMNvl. 
3.4.2 Esr1 and Pgr mRNA Levels 
In ovariectomized adult rats, exposure to E2 reduced Esr1 mRNA levels in the 
AVPV, SDN-POA and VMNvl (Fig. 3.7.2 a, b and c, respectively).  P4 administration 
significantly decreased Esr1 mRNA levels in the AVPV (Fig. 3.7.2a), but not in the 
SDN-POA (Fig. 3.7.2b) or VMNvl (Fig. 3.7.2c).  In all three areas examined, E2+P4 
reduced levels of mRNAs encoding Esr1 (Fig. 3.7.2a, b and c).  E2 markedly increased 
levels of mRNA encoding Pgr in all brain regions examined (Fig. 3.7. 2d, e and f), and 
in the AVPV and SDN-POA, E2+P4 increased Pgr mRNA levels. 
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3.4.3 Pgrmc1, Serbp1 and Pgrmc2 mRNA Levels 
In the AVPV, mRNA levels of the homologues Pgrmc1 and Pgrmc2 were 
unaltered by treatment with E2, P4 or E2+P4 (Fig. 3.7.3a and d).  Within the SDN-POA, 
Pgrmc1 and Pgrmc2 levels were not significantly affected by E2 or P4 alone, but E2+P4 
increased Pgrmc1 (Fig. 3.7.3b) and decreased Pgrmc2 mRNA levels (Fig. 3.7.3e).  In 
the VMNvl, P4 increased Pgrmc2 mRNA levels (Fig. 3.7.3f).   
Levels of mRNA encoding Pgrmc1 and its binding partner, Serbp1, were 
increased by P4 or E2+P4 in the VMNvl (Fig. 3.7.3c and i).  In the SDN-POA, only 
E2+P4 increased Pgrmc1 and Serbp1 mRNA levels (Fig. 3.7.3b and h).  In the AVPV, 
E2+P4 increased Serbp1 (Fig. 3.7.3g), but not Pgrmc1 mRNA levels (Fig. 3.7.3a).  
3.4.4 Paqr7 and Paqr8 mRNA levels 
Ovarian steroids did not regulate Paqr7 mRNA levels in any brain region 
examined (Fig. 3.7.4a, b and c).  In contrast, Paqr8 mRNA levels were repressed by 
treatment with P4 in the AVPV (Fig. 3.7.4d), increased by E2 in the SDN-POA (Fig. 
3.7.4e), but not altered in the VMNvl (Fig. 3.7.4f). 
3.5 Discussion 
These results are the first to show that E2 and P4 regulate non-classical progestin 
signaling molecules in the AVPV, SDN-POA and VMNvl.  Significantly, E2+P4 
increased Serbp1 mRNA levels in all brain regions examined, but increased expression 
of its putative binding partners, Pgrmc1 and Pgrmc2, in a region-specific manner.  
These findings are consistent with the idea that Serbp1 availability is the key factor 
determining P4 responsiveness of Pgrmc1 complexes (Peluso et al., 2004).  Ovarian 
steroid regulation of Paqr8 also varied by brain region; however, the closely-related 
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Paqr7 was not regulated in any region examined.  Together these findings support the 
hypothesis that Pgrmc1, Pgrmc2, Serbp1 and Paqr8 mediate rapid P4 signaling within 
neuroendocrine nuclei important for female reproduction. 
Our findings that E2 decreased Esr1 and increased Pgr in the AVPV and VMNvl 
are similar to results of previous studies (Lauber et al., 1990, Simerly and Young, 
1991).  We now report that the same pattern exists in the SDN-POA.  Interestingly, in 
the VMNvl, P4 abrogated the effects of E2 on Pgr mRNA levels.  Although this was not 
seen in other brain regions examined herein, P4 blocks E2 induction of Pgr in non-neural 
cells (Kraus and Katzenellenbogen, 1993).   
We found that E2+P4 increased Pgrmc1 mRNA levels in the SDN-POA but not 
the AVPV; however, in both regions Serbp1 expression was increased, and this may be 
sufficient for rapid P4 effects.  This idea is supported by findings that P4 responses 
mediated by the Pgrmc1/Serbp1 complex depend upon Serbp1 levels in non-neural cells 
(Peluso et al., 2005).  Interestingly, E2+P4 increased Pgrmc2 mRNA levels in the 
AVPV, though no studies have tested whether Serbp1 binds Pgrmc2 to form a 
functional complex.  These mechanisms are of particular interest as the AVPV is 
required for induction of the preovulatory luteinizing hormone surge (Wiegand et al., 
1980, Ronnekleiv and Kelly, 1986, Petersen et al., 1995, Chappell and Levine, 2000).  
The AVPV and SDN-POA have dense projections to GnRH neurons (Simonian et al., 
1999), and show abundant Pgrmc1, Pgrmc2 and Serbp1 mRNA levels (Intlekofer and 
Petersen, 2011).  Thus, further studies are warranted to determine whether these 
signaling molecules mediate rapid P4 effects in the AVPV and SDN-POA. 
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P4 and E2+P4 increased Pgrmc1 and Serbp1 mRNA levels in the VMNvl, a 
region in which P4 facilitates lordosis (Pfaff and Sakuma, 1979, Pfaff et al., 1994, Frye 
and Vongher, 1999, Frye, 2001). These rapid P4 effects are partially due to activation of 
cGMP-dependent protein kinase (DeBold and Frye, 1994, Lydon et al., 1995).  This is 
especially interesting because Pgrmc1 is involved in P4 induction of cGMP-dependent 
protein kinase (Peluso and Pappalardo, 2004), and the C-terminus of Pgrmc1 contains 
several putative kinase binding sites (Cahill, 2007).  Other researchers examining the 
entire VMN also found that Pgrmc1 was regulated by ovarian steroids; however, in that 
study E2 alone increased Pgrmc1 mRNA levels (Krebs et al., 2000).  Factors that may 
explain these differences include dosage, duration of treatment, and region examined.  
Overall, these findings suggest a link between Pgrmc1/ Serbp1 and the rapid facilitation 
of feminine sex behavior.   
 Our findings are the first to show that ovarian steroids regulate Paqr8 mRNA 
levels in the brain.  Similar to studies in myometrial cells, we found that E2 increased 
both Paqr8 and Pgr mRNA levels in the SDN-POA.  These results are interesting in 
light of evidence that Paqr8 cross-talks with Pgr through coupling to inhibitory G-
proteins and decreasing Pgr transactivation (Karteris et al., 2006).  In contrast to Paqr8, 
ovarian steroid exposure did not alter Paqr7 mRNA levels in any brain region 
examined.  In other reproductive tissues, E2 and P4 also have variable effects on these 
signaling molecules (Cai and Stocco, 2005, Fernandes et al., 2005).  Thus, despite their 
structural similarities, Paqr7 and Paqr8 may be regulated differently by ovarian steroids 
and may have functionally distinct roles.       
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  Though reproductive functions coordinated by ovarian hormones have been 
studied extensively, the underlying molecular events are unclear.  The present studies 
identified several steroid-inducible progestin signaling molecules that may mediate 
rapid P4 actions in the neuroendocrine control of reproduction.  The functional 
relevance and specific role(s) of these novel signaling molecules will be the topic of 
future research. 
  
 64 
 
3.6.1: Primers Used in QPCR Studies 
NCBI Gene Name   
and Refseq ID# Primer sequences 5’- 3’ 
Antisense 
to bases 
Amplicon 
(bp) 
Actb 
NM_031144 
GGGAAATCGTGCGTGACATT 698 – 717 
76 
GCGGCAGTGGCCATCTC 773 – 757 
Esr1 
NM_012689 
AGTGAAGCCTCAATGATGGG 1236 – 1255 
146 
ATCTCCAACCAGGCACACTC 1381 – 1362 
Pgr 
NM_022847 
GGTGGAGGTCGTACAAGCAT 2261 – 2280 
214 
AGGCCTTCCAAAGGAATTGT 2474 – 2455 
Pgrmc1 
NM_021766 
CTGCCGAACTAAGGCGATAC 321 – 340 
247 
TCCCAGTCATTCAGGGTCTC 567 – 548 
Pgrmc2 
NM_001008374 
AGCAGCTGCGCCAGTACGAC 306 – 325 
139 
GAGGCGTCCCTGCCAGCAAA 444 – 425 
Serbp1 
NM_145086 
GAAACACCCGAAGGTGAAGA 789 – 808 
190 
TTTTCCATTGTCCATCAGCA 978 – 959 
Paqr7 
NM_001034081 
GTGCACCGCATCATAGTGTC 661 – 680 
230 
TGATAGTCCAGCGTCACAGC 890 – 871 
Paqr8 
NM_001014099 
CTGCAGCCTCTTGGCCCACC 825 – 844 
179 
CAGCCGCCGGCAGGAAGAAA 1003 – 984 
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3.7.1 Diagram of Brain Sections 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7.1: Diagrams of brain sections containing the a) AVPV, b) SDN-POA 
and c) VMNvl modified from the atlas of Swanson (1998).  Circles indicate regions 
from which tissue was excised for analysis.  OC, optic chiasm; 3V, third ventricle; 
AC, anterior commissure. 
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3.7.2 Esr1 and Pgr mRNA Levels  
 
 
 
Figure 3.7.2: Levels of mRNAs encoding Esr1 and Pgr in ovariectomized rats 
treated with oil, E2, P4 or E2+P4.  Esr1 mRNA levels in the AVPV (a), SDN-POA 
(b) and VMNvl (c), and Pgr mRNA levels in the AVPV (d), SDN-POA (e) and 
VMNvl (f) were determined by QPCR.  Bars = means ± SEM.  a Significantly 
different from oil-treated controls; b significantly different from E2-treated 
animals; c significantly different from P4-treated animals; values considered 
significantly different if p < 0.05 in post-hoc analyses.  One-way ANOVA results: a) 
F(3,22) = 4.72 1, p < 0.010; b) F(3,20) = 11.81, p < 0.0002; c) F(3,20) = 8.14, p < 
0.001; d) F(3,20) = 20.83, p < 0.0001; e) F(3,20) = 17.14, p < 0.0001; f) F(3,20) = 
41.49, p < 0.0001. 
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 3.7.3 Pgrmc1, Serbp1 and Pgrmc2 mRNA Levels 
 
 
 
Figure 3.7.3: Levels of mRNAs encoding Pgrmc1, Pgrmc2 and Serbp1 in 
ovariectomized rats treated with oil, E2, P4 or E2+P4.  Pgrmc1 mRNA levels in the 
AVPV (a), SDN-POA (b) and VMNvl (c), Pgrmc2 mRNA levels in the AVPV (d), 
SDN-POA (e) and VMNvl (f), and Serbp1 mRNA levels in the AVPV (g), SDN-
POA (h) and VMNvl (i) were determined by QPCR.  Bars = means ± SEM.  a 
Significantly different from oil-treated controls; b significantly different from E2-
treated animals; c significantly different from P4-treated animals; values 
considered significantly different if p < 0.05 in post-hoc analyses.  One-way 
ANOVA results: a) F(3,22) = 2.32, p < 0.103; b) F(3,20) = 8.56, p < 0. 0.001; c) 
F(3,22) = 28.59, p < 0.0001; d) F(3,22) = 21.79, p <0.0001; e) F(3,22) = 6.56, p < 
0.002; f) F(3,22) = 21.13, p < 0.0001; g) F(3,22) = 4.65, p < 0.01; h) F(3,22) = 4.55, p 
< 0.01; i) F(3,22) = 6.16, p < 0.003. 
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 3.7.4 Paqr7 and Paqr8 mRNA Levels 
 
 
 
 
Figure 3.7.4: Levels of mRNAs encoding Paqr7 and Paqr8 in ovariectomized rats 
treated with oil, E2, P4 or E2+P4.  Paqr7 mRNA levels in the AVPV (a), SDN-POA 
(b) and VMNvl (c), and Paqr8 mRNA levels in the AVPV (d), SDN-POA (e) and 
VMNvl (f) were determined by QPCR. Bars = means ± SEM.  a Significantly 
different from oil-treated controls; b significantly different from E2-treated 
animals; c significantly different from P4-treated animals; values considered 
significantly different if p < 0.05 in post-hoc analyses.  One-way ANOVA results: a) 
F(3,22) = 0.65, p < 0.59; b) F(3,22) = 0.037, p < 0.99; c) F(3,20) = 3.67, p < 0.03; d) 
F(3,22) = 10.39, p < 0.0002; e) F(3,22) = 33.87, p < 0.0001; f) F(3,20) = 1.35, p < 0.29. 
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CHAPTER 4 
DUAL-LABEL IN SITU HYBRIDIZATION REVEAL THAT PGRMC1 AND 
SERBP1 ARE COLOCALIZED WITHIN GABAERGIC NEURONS OF THE 
ANTEROVENTRAL PERIVENTRICULAR NUCLEUS OF THE FEMALE RAT 
4.1 Abstract 
The neural control of ovulation requires generation of the gonadotropin 
releasing hormone (GnRH) and luteinizing hormone (LH) surges by 17β-estradiol (E2) 
and progesterone (P4).  While the majority of research in this field concerns the 
essential role of E2, the role of P4 in the preovulatory surge is less understood.  
Numerous studies in rats have shown that P4 controls the timing and amplification of 
the LH surge.  While the exact neurobiological mechanisms that underlie these actions 
remain unclear, they are likely to occur through P4 action in the preoptic area and 
hypothalamus, brain regions with abundant classical progesterone receptors (Pgr).  We 
recently found that these regions also express high levels of progesterone signaling 
molecules, including Progesterone Receptor Membrane Component 1 (Pgrmc1) and 
Serpine mRNA Binding Protein 1 (Serbp1), indicating that these additional molecules 
may subserve progesterone actions in the preovulatory surge.  To begin to test this idea, 
we used dual-label in situ hybridization to determine whether these progesterone 
signaling molecules are colocalized in neurons critical for the LH surge mechanism.  
We now report that the majority of neurons important for the neural control of ovulation 
contain Pgrmc1 and Serbp1 mRNA, and both signaling molecules are colocalized in the 
same neurons.  Together, these findings indicate that progesterone actions in regulation 
of the LH surge may involve progesterone signaling molecules, Pgrmc1 and Serbp1.    
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  In line with this idea, Pgr is abundantly expressed in the hypothalamus, but we 
and others have recently found progesterone signaling molecules in hypothalamic 
regions known to be important for generation of the LH surge.     
4.2 Introduction 
Although the regulation of the luteinizing hormone (LH) surge by 17β-estradiol 
(E2) and progesterone (P4) has been studied extensively, the molecular actions of these 
steroid hormones continue to emerge.  In the neural control of the preovulatory surge, 
hormonal status is conveyed to gonadotropin releasing hormone (GnRH) neurons by 
neural projections that originate in the anteroventral periventricular nucleus (AVPV) 
(Simonian et al., 1999, Ottem et al., 2004).  Previous findings show that these important 
AVPV neurons are dual-phenotype GABA/glutamate neurons (Ottem et al., 2004), and 
contain abundant E2 and P4 receptors (Simerly et al., 1990{Shughrue, 1997 #1045).  
While E2 is a requisite hormone for the onset of the GnRH and LH surges, P4 regulates 
more subtle aspects of the surge including the timing and amplification (Everett, 1948, 
Rothchild, 1965, DePaolo and Barraclough, 1979), though P4 actions in this capacity are 
not well understood.  New insights into P4 mechanism of action have identified novel 
signaling molecules that may be involved in modulating the LH surge.  In support of 
this idea, we recently reported that the AVPV contains progesterone receptor membrane 
component-1 (Pgrmc1) and binding partner Serpine mRNA binding protein 1 (Serbp1) 
(Intlekofer and Petersen, 2010).  Thus, P4 signaling molecules in the AVPV may 
mediate important P4 effects in the neural control of the preovulatory LH surge. 
Pgrmc1 and Serbp1 are binding partners that mediate P4 actions in other tissues 
(Peluso et al., 2004, Peluso et al., 2008), but it is unclear whether they could play a 
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similar role in dual-phenotype neurons.  While this possibility has not yet been 
explored, several lines of evidence support the idea that P4 signaling molecules such as 
Pgrmc1 and Serbp1 could mediate P4 actions in regulation of the surge.  For example, 
membrane bindings sites for P4 have been identified in the hypothalamus (Ke and 
Ramirez, 1990), and P4 exerts rapid Pgr-independent effects (Frye and Vongher, 2001, 
Sleiter et al., 2009).  Given the important role of GABA/glutamate neurons of the 
AVPV, and high expression of hormone receptors in the AVPV region, it is possible 
that additional P4 signaling molecules account for the effects of P4 on LH surge release.  
To address this issue, we used dual-label in situ hybridization histochemistry (ISHH) to 
determine whether AVPV GABA/glutamate neurons contain Pgrmc1 and Serbp1 and 
whether these signaling molecules are coexpressed by AVPV neurons.   
4.3. Materials and Methods 
4.3.1 Animals and Tissues 
All animals were housed in accordance with the National Institutes of Health 
Guidelines for the Care and Use of Laboratory Animals and all protocols were approved 
by the Institutional Animal Care and Use Committee of the University of 
Massachusetts.  We used brains from six adult female Sprague-Dawley rats (200-225 g, 
Harlan, Madison, WI).  Animals were housed on a 14:10 light:dark cycle with free 
access to food and water, and ovariectomized under isofluorane anesthesia.  A week 
later, the rats received s.c. implants of Silastic capsules (Dow Corning, Midland, MI; 
1.57 mm, o.d., 3.8 mm; 30 mm length) containing E2 (150 µg/ml in sesame oil) as 
previously described (Petersen et al., 1995).  After two days, rat brains were collected at 
1500 h and rapidly frozen on powdered dry ice.  Brains were cryosectioned (Leica 
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CM3000, Nussloch, Germany) at 14 µm through the rostral preoptic area, a brain region 
that contains the AVPV.  Sections were thaw-mounted onto gelatin-coated slides, dried 
briefly at 42ᵒ C on a slide warmer, and stored at -80ᵒ C until prehybridization.   
4.3.2 Transcription Template Preparation 
PCR-generated transcription templates for rat Pgrmc1 and Serbp1 were 
produced using rat cDNA and GoTaq® Green Master Mix and manufacturer’s protocol 
(Promega, Madison, WI).  Specific primer sets were obtained from Integrated DNA 
Technologies (Coralville, IA) and sequences are listed in Table 4.6.1.  Reactions were 
performed in an Eppendorf Thermocycler (Hauppauge, NY) programmed as follows: 95 
°C, 10 min, 40 cycles of 95 °C for 15 sec and 60 °C for 60 sec.  PCR products were 
purified by gel electrophoresis and extracted using GenElute™ Agarose Spin-Columns 
and manufacturer’s protocol (Sigma-Aldrich, St. Louis, MO).  The resulting cDNA 
fragments were inserted into vectors using the TOPO-TA® cloning kit (Invitrogen, 
Carlsbad, CA).  One Shot Mach1 T1-phage resistant E.Coli (Invitrogen) were 
transformed with plasmids containing the cDNA fragments and plasmids were isolated 
with the QIAfilter Plasmid Mini kit (Qiagen).  The identity and direction of each insert 
was confirmed by sequencing provided by Genewiz (South Plainfield, NJ.)   
For detection of GABAergic cells, cDNA templates for Gad1 and 2 were 
produced as described previously (Hays et al., 2002).  Primers used to generate 
templates for Pgr, Gad1 and Gad2 are specified in Table 4.6.  To produce template for 
rat GnRH cRNA probes, I linearized a modified pSP65 plasmid containing a 330-bp 
cDNA fragment (provided by Dr. John Adelman, Vollum Institute, Portland, OR).  This 
fragment corresponds to exons I-IV of mRNA encoding GnRH (Adelman et al., 1986). 
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Plasmids were linearized using restriction sites present within the vector and 
restriction enzymes (Promega).  Linearized templates were extracted with 
phenol/chloroform, precipitated with 0.4 M NaCl2 and ethanol and stored in 10 mM 
Tris and 1 mM EDTA (TE; pH 8.0) at -20 C until they could be used for transcription of 
cRNA probes.   
4.3.3 Probe preparation 
The cDNA templates were transcribed as described previously (Petersen et al., 
1993) and all enzymes were provided by Promega.  Briefly, I used a DNA SpeedVac 
(Savant, Farmingdale, NY) to dry 120 pmol (12 µM final concentration) of 35S-UTP 
(PerkinElmer, Boston, MA).  To generate radiolabeled probes for Pgrmc1 and Serbp1, I 
added the following in a total volume of 10 µl: 0.5 mM linearized template, 1X 
transcription buffer, 10 mM dithiothreitol (DTT), 20 U RNAsin, 3 µM UTP, 0.5 mM 
each ATP, CTP, and GTP and 10 U RNA polymerase.  Each reaction was incubated for 
30 min at 37◦ C, then a second 10 U RNA polymerase aliquot was added, mixed and 
incubated for 30 min at 37◦ C.  Deoxyribonuclease I (20 U) was added to each reaction 
to degrade the DNA template in the presence of 20 U RNAsin.  The transcription 
reaction volume was adjusted to 100 µl by addition of TE, 0.4 M NaCl2 and 0.5 µl 
tRNA.  I extracted cRNA probes with phenol-chloroform, removed unincorporated 
nucleotides by ethanol precipitation and resuspended them in 100 µl TE.   
GABAergic cells were detected using a mixture of digoxigenin-labeled cRNA 
probes encoding Gad1 and 2 and prepared as previously described (Hays et al., 2002).  I 
also generated digoxigenin-labeled probes to detect GnRH neurons as described 
previously (Sannella and Petersen, 1997).  For both Gad and Serbp1 detection, I 
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produced digoxygenin-labeled probes using 1 µg linearized cDNA template, 1X 
transcription buffer, 500 µM each ATP, CTP and GTP, 50µM UTP, 10 mM DTT and 
20 U RNA polymerase in the presence of 250 µM digoxigenin-11-UTP (Roche, 
Molecular Biochemicals, Indianapolis, IN).  The mixture was incubated at 37◦ C for 1 h 
and then an additional 20 U RNA polymerase aliquot was added and incubation 
continued for another hour.  I eliminated the DNA template using 20 U 
deoxyribonuclease I in the presence of 20 U RNasin.  The reaction volume was adjusted 
to 100 µl by the addition of nuclease-free water, precipitated twice with 0.4 M NaCl2 
and ethanol, and then resuspended in 100 µl TE.    
4.3.4 In situ hybridization  
Tissue sections were prehybridized as previously described (Ottem et al., 2004).  
Nonisotopic and radiolabeled cRNA probes were added to hybridization buffer 
consisting of 50 % formamide, 1XSSC, 20 % dextran sulfate, 1X Denhardt's solution 
(0.02 % Ficoll-400, 0.02 % bovine serum albumin, 0.02 % polyvinylpyrrolidone-40), 
500 µg/ml yeast tRNA, 500 µg/ml heparin sodium salt, 0.1 % sodium pyrophosphate 
and freshly prepared 400 mM DTT was added before use.  Twenty µl of hybridization 
buffer containing cRNA probes (1.0 x 106 cpm radioisotopic probe and 1 µl 
digoxigenin-labeled probe) was applied to each tissue section and covered with glass 
coverslips, and then sections were incubated for 16 h at 52 C.  Additionally, 
representative sections were hybridized to radiolabeled sense probes for Pgrmc1 and 
Serbp1 in order to verify specificity.  Specificity of probes for Gad 1 and 2 were 
determined previously (Ottem et al., 2004).   
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4.3.5 Signal detection 
Posthybridization was performed on an orbital or lateral shaker at room 
temperature unless otherwise specified.  Coverslips were removed and the slides were 
washed as follows: 50 % (v/v) formamide/2XSSC for 40 min at 52 C; 2XSSC for 20 
min; RNase buffer (0.5 M NaCl, 10 mM Tris; and 1 mm EDTA; pH 8.0) containing 25 
µg/ml RNAse A (Roche) for 30 min at 37 C; 2XSSC for 10 min; 50% (v/v) 
formamide/2XSSC for 20 min; and 2XSSC for 10 min.  Next, I processed slides for 
immunocytochemical detection of digoxigenin. 
Nonspecific binding was blocked by placing tissue sections in a solution 
containing  0.5% w/v blocking reagent (Roche) in maleate buffer (100 mM maleic acid, 
150 mM NaCl; pH 7.5) and 0.3 % Triton X-100 for 1 h.  Slides were washed twice for 5 
min in 0.1 M Tris-HCl and 0.15 M NaCl (TN) and then incubated at 4◦ C in 0.2 % w/v 
blocking reagent (Roche) and anti-digoxygenin antisera conjugated to horseradish 
peroxidase (Roche; 1:150) using probe clips (Midwest Scientific, PC200) without 
shaking.  After 48 h, probe clips were removed and slides were washed in maleate 
buffer, TN, and TN with 0.05% TritonX; Sigma-Aldrich (TNT) for 5 min each.   Slides 
were transferred to plastic mailers containing biotinylated tyramide from a Renaissance 
TSA-indirect ISH Kit (Perkin-Elmer; 1:250) in TNT for 10 min.  Sections were washed 
in TNT three times for 3 min each and then incubated in ABC Elite (Vectastain ABC 
Kit, Vector Laboratories, Burlingame, CA) reagent for 30 min at 37◦ C using probe clips 
and manufacturer’s protocol.  Probe clips were removed and slides washed 3 times, 3 
min each in TNT.  Digoxigenin signal was visualized using TNT containing 1 mM 
diaminobenzidine (Sigma D5905) and 0.1 mM hydrogen peroxide.  After specific signal 
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appeared, this reaction was halted by rinsing slides in 0.1 M Tris (pH 7.6) for 3 min 
followed by a brief rinse in water.  Finally slides were dehydrated for 3 min in 70 % 
ethanol and air-dried.   
I detected radioisotopic probe signal autoradiographically using NTB emulsion 
(Kodak, Rochester, NY) and manufacturer’s protocol.  Slides were later developed at 
14◦ C using Kodak Dektol developer and Kodak fixer.  After a rinse in water, I air-dried 
the slides and dipped them briefly in xylenes prior to coverslipping with Cytoseal 60™ 
mounting medium (Richard-Allan Scientific, Kalamzoo, MI).  Images were acquired 
using a CCD videocamera (QImaging QICAM FAST color) and BioQuant Imaging 
Software (Nashville, TN).  
4.3.6 Statistics 
 In order to analyze dual-label ISHH studies, I used four to six AVPV sections 
from each animal and determined the mean number of GAD-positive neurons 
containing Pgrmc1 and the mean number containing Serbp1 mRNA.  This value was 
used to determine the percentage of GAD-positive neurons that contained specific 
signal for Pgrmc1 or Serbp1.  Similarly, percentages of Serbp1-positive neurons that 
contained specific Pgrmc1 signal were also determined.  Signal was considered specific 
if the digoxigenin-labeled neurons contained four-times more 35S-labeled probe signal 
than background.  The grand means of each group were acquired from the means of 
individual animals.  
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4.4 Results  
4.4.1 AVPV GABA Neurons Contain Pgrmc1 mRNA 
 Results of the dual-label ISHH studies showed that in E2-primed ovariectomized 
female rats, AVPV neurons that were GAD-positive (as determined using digoxigenin-
labeled cRNA probes for GAD1 and 2) contain Pgrmc1 mRNA (Figure 4.6.1a).  
Quantification studies determined that virtually all GABAergic neurons contain Pgrmc1 
mRNA (Figure 4.6.1d). 
4.4.2 AVPV GABA Neurons Contain Serbp1 mRNA 
 In the AVPV, neurons that contained GAD mRNA also contained Serbp1 
mRNA (Figure 4.6.1b).  Serbp1 mRNA was specifically detected in approximately 86% 
of GAD-positive neurons in ovariectomized E2-primed rats (Figure 4.6.1d).   
4.4.3 Pgrmc1 and Serbp1 mRNA are Coexpressed by AVPV Neurons 
 Dual-labeling experiments revealed that Pgrmc1 and Serbp1 mRNA are present 
within the same neurons in the AVPV of ovariectomized E2-primed female rats (Figure 
4.6.1c).  Pgrmc1 (detected using a radioactively-labeled probe) was specifically 
expressed by approximately 94% of Serbp1+ neurons in ovariectomized E2-primed rats 
(Figure 4.6.1d).  A small percentage of AVPV neurons that were Serbp1+ did not 
contain detectable levels of Pgrmc1 signal. 
4.5 Discussion 
 The present findings are the first to show that AVPV cells contain mRNA 
encoding both Pgrmc1 and binding partner Serbp1.  Moreover, nearly all expression of 
these two genes was within GABAergic neurons (as determined by using GAD as a 
marker of GABAergic neurons).  Given the importance of these GABAergic neurons in 
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relaying hormonal cues to GnRH neurons, our findings indicate that P4 may exert 
diverse actions through Pgrmc1 and Serbp1 in timing and amplifying the LH surge.  
The finding that Pgrmc1 and Serbp1 mRNAs are contained within the same AVPV 
neurons lends support to the notion that these binding partners form a functional 
receptor complex to mediate P4 actions in AVPV neurons as they do in granulosa cells 
(Peluso et al., 2004, Peluso et al., 2006).  Taken together, these data indicate that 
Pgrmc1 and Serbp1 actions as P4 signaling molecules may be important in the neural 
control of ovulation.    
 The neural expression of Pgrmc1 and Serbp1 within GABAergic AVPV neurons 
is intriguing as these neurons are critical for regulation of LH surge release.  Ample 
evidence supports the idea that GABA release from AVPV efferents restrains GnRH 
firing and the onset of the surge.  For example, GABA release within the vicinity of 
GnRH cell bodies increases in the morning but falls before the afternoon onset of the 
LH surge (Robinson et al., 1991, Jarry et al., 1995).  In the AVPV, levels of Gad1 
mRNA (marker of GABAergic neuronal activiation), as well as the amount of vesicular 
GABA transporter in synapses on GnRH neurons (Ottem et al., 2004) rise, then fall just 
before LH surge release.  These changes parallel those of GABA release into the 
preoptic area on the day of the surge (Jarry et al., 1995)  and a decline in GABA is 
required for LH surge release (Herbison and Dyer, 1991, Seltzer and Donoso, 1992).  
GnRH neurons express GABAA receptors (Petersen et al., 2003), and GABAA activation 
hyperpolarizes GnRH neurons (Herbison, 1998, Han et al., 2002).  Together, these 
findings highlight the importance of AVPV GABergic neurons and underscore the 
importance of this subset of neurons as a nodal point conveying hormonal status to 
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GnRH neurons.  Thus, the present finding that P4 signaling molecules are present on the 
vast majority of GABAergic neurons suggests that they may influence the regulatory 
input of AVPV dual-phenotype neurons to GnRH cell bodies.    
 The exact role of P4 in the LH surge release is an issue that has been difficult to 
resolve as E2 alone is sufficient to increase GnRH levels in the neural control of the LH 
surge (Rothfeld et al., 1989, Rosie et al., 1990).  Therefore, our understanding on this 
topic is centered on the observation that P4 coordinates the timing of the onset as well as 
increasing the magnitude of the LH surge (Everett, 1948, Rothchild, 1965, DePaolo and 
Barraclough, 1979).  This positive-feedback action is largely attributed to E2-induced 
Pgr activation (Chappell and Levine, 2000), a highly induced gene in the estrogen 
receptor-rich AVPV (Simerly et al., 1990, Shughrue et al., 1997).  Our current findings 
suggest another alternative, namely that P4 activation of Pgrmc1 and Serbp1 may 
contribute to the regulatory functions of P4 on LH surge magnitude and timing.  While 
further research concerning this possibility is warranted, evidence from other cells 
support the concept that Pgrmc1 and Serbp1 may mediate P4 signaling in AVPV 
neurons. 
 Our finding that Pgrmc1 and Serbp1 are coexpressed within the same cells is in 
line with the idea that both are required for P4 actions.  Current research on these 
binding partners shows that depletion of Pgrmc1 or Serbp1 limits the ability of P4 to 
maintain cell viability in granulosa cells (Peluso et al., 2004, Peluso et al., 2008).  
Additional studies have shown that Pgrmc1overexpression increases [3H]-P4 binding 
and P4-responsiveness (Peluso et al., 2006), indicating that Pgrmc1 mediates P4 actions.  
This idea appears to hold for some neural cells, as a recent study reports that Pgrmc1 is 
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required for the proliferative effect of P4 on hippocampal neuroprogenitor cells (Liu et 
al., 2009).  Although the roles of Pgrmc1 and Serbp1 in mediating neural responses to 
P4 remains unknown, our present findings raise the possibility that may be important in 
the AVPV for P4-dependent amplification of LH surge release.   
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4.6.1: Primers Used in Template Production 
NCBI Gene 
Name and 
Accession # 
Primer sequences 5’- 3’ Antisense to bases: 
Amplicon 
(bp) 
rat Gad1 
NM_017007 
GATCCTAATACTACCAACCTGC 231 – 253 
537 
ACCAGCTCTCTACTGGTTTGGA 746 – 767 
rat Gad2 
NM_012563 
CGTGACCTCGCGGGCCGCCA 257 – 276 
688 
TTCTCTCAAGAAGGGAGCTGCA 923 – 944 
rat Gad2 
NM_012563 
GCCTTGGGGATCGGAACAGACA 945 – 966 
825 
ATGGTCATCTCAAACCCTGCA 1749 – 1769 
rat Pgrmc1 
NM_021766 
TCCAGAGATCATGGCTGC 88 – 105 
678 
CATGTTGTAAAGACAGACTGG 765 – 745 
rat Serbp1 
NM_145086 
CAACCGATTCGACCAGCTAT 107 – 126 
702 
TCTTCACCTTCGGGTGTTTC 808 – 789 
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4.7.1 Pgrmc1 and Serbp1 are Coexpressed by GABAergic AVPV Neurons  
  
Figure 4.7.1: Most GABAergic neurons (Gad-positive) of the adult female rat 
contain Pgrmc1 (A) and Serbp1 (B), and Pgrmc1 and Serbp1 are coexpressed 
within many of the same neurons (C).  Dual-label ISHH used 35S-labeled cRNA 
probes (black grain) and digoxigenin-labeled cRNA probes (brown stain) and 
adult female rat brain sections containing the AVPV.  Photomicrographs were 
produced using probes 35S-labeled for Pgrmc1 (A, C) and Serbp1 (B), in 
combination with digoxigenin-labeled GAD (marker of GABAergic neurons) (A, 
B), and Serbp1 (C).  Quantification of colocalization experiments is shown in D. 
Scale bar = 50 µm.   
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CHAPTER 5 
PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1 
COREGULATES NOVEL GENE TARGETS NR4A1, SPNA1, TGM2 AND IFIT3 
AND REGULATES BASAL STAT3 ACTIVATION IN NEURAL CELLS 
5.1 Abstract 
 Progesterone receptor membrane component 1 (Pgrmc1) is a signaling molecule 
important for progesterone actions in reproductive tissues.  While much of the research 
regarding Pgrmc1 function has been conducted in ovarian cells, we and others have 
recently found high levels of Pgrmc1 expression in the brain, particularly in the rat 
hypothalamus.  In these studies, we extend the anatomical localization to mouse brain 
and found high levels of Pgrmc1 mRNA in hypothalamic nuclei, yet the roles of 
Pgrmc1 in neural cells is not yet clear.  At the cellular level, Pgrmc1 has been localized 
to the nucleus, suggesting a role in transcription.  In order to investigate this possibility, 
we used whole-genome microarrays to examine the effects of Pgrmc1 levels on gene 
expression in a hypothalamic cell line.  We report that Pgrmc1 co-regulates several gene 
targets, including nuclear receptor subfamily 4 group A member 1 (Nr4a1), interferon-
induced protein with tetratricopeptide repeats 3 (IFIT3), spectrin alpha 1 (Spna1) and 
transglutaminase 2 (Tgm2).  Given the role of Pgrmc1 in signaling pathways of diverse 
tissues, we used pathway analysis software on our microarray data to determine if 
Pgrmc1regulates signaling pathways in neural cells.  We found that Pgrmc1 regulates 
basal levels of STAT3 activation in a manner that may explain Pgrmc1 coregulation of 
several target genes.  Thus, we propose a novel role of Pgrmc1 in neural cells in 
regulation of STAT3 pathways and in regulating novel target genes.      
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5.2 Introduction 
 The observation that progesterone exerts rapid effects in diverse tissues has led 
the discovery of several novel signaling molecules.  Among these molecules, 
Progesterone Receptor Membrane Component 1 (Pgrmc1) has been implicated in a 
wide array of physiological functions.  For example, Pgrmc1 is required for the 
apoptotic actions of progesterone (P4) in granulosa cells (Peluso et al., 2006, Peluso et 
al., 2008).  In adrenal cells, Pgrmc1 mediates steroid biosynthesis and metabolism 
through interactions with enzymes in the biosynthetic pathway (Laird et al., 1988, Min 
et al., 2004, Hughes et al., 2007).  Finally, in sperm cells, Pgrmc1 is implicated in the 
P4-induced calcium influx that precedes the acrosome reaction (Buddhikot et al., 1999, 
Falkenstein et al., 1999).  Together, these data indicate that Pgrmc1 may regulate 
divergent effects depending on the tissue type.   
 While Pgrmc1 has been most studied in non-neural tissues, high levels of 
Pgrmc1 have also been found in the brain, indicating that Pgrmc1 may play an 
important role in neural functions (Krebs et al., 2000, Intlekofer and Petersen, 2011).  
Pgrmc1 expression is also found in vasopressinergic neurons of the paraventricular 
nucleus (Meffre et al., 2005), a finding that may point to a role in water homeostasis.  
Though these studies yield clues as to the potential roles of Pgrmc1, the specific neural 
actions of Pgrmc1 have not been identified.  
 At the cellular level, evidence suggests that Pgrmc1regulates diverse signaling 
pathways and transcriptional events, though the cellular actions of Pgrmc1are likely to 
vary depending on the cell type.  In breast cancer cells, Pgrmc1 activates Akt and IκB 
through phosphorylation (Hand and Craven, 2003) while in hippocampal neural 
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progenitor cells, Pgrmc1 is required for ERK pathway activation (Liu et al., 2009).  
Pgrmc1 may also alter transcription of target genes as supported by evidence that 
Pgrmc1 localizes to the nucleus (Beausoleil et al., 2004, Peluso et al., 2006) and may 
regulate cell proliferation and pro-survival genes (Liu et al., 2009, Peluso et al., 2010).   
Despite this wide range of clues, virtually nothing is known regarding Pgrmc1-
dependent signaling pathways and gene targets in hypothalamic neural cells, where 
Pgrmc1 expression levels are especially abundant.  In order to address this issue, we 
used a hypothalamic cell line and Pgrmc1 small interfering RNA (siRNA) to knock 
down Pgrmc1 expression, and identified novel gene candidates and Pgrmc1-dependent 
signaling pathways using microarray analyses.   
5.3 Materials and Methods 
5.3.1 Animals and Tissue Preparation 
 All animals were housed in accordance with the National Institutes of Health 
Guidelines for the Care and Use of Laboratory Animals and all protocols were approved 
by the Institutional Animal Car and Use Committee of the University of Massachusetts.  
Three adult female C57Bl/6 mice (21-22 g; Jackson Labs; Bar Harbor, ME) were 
communally housed in the Animal Care Facility with food and water provided ad 
libitum on a 14:10 light:dark cycle.  Animals were ovariectomized under isofluorane 
anesthesia, allowed to recover for one week, and then injected s.c. with 10 µM 17β-
estradiol dissolved in 100 µl sesame oil to ensure a similar hormonal milieu among 
animals.  After 8 h, brains were collected and rapidly frozen on powdered dry ice and 
stored at -80ᵒ C until they were cryosectioned (Leica CM3000, Nussloch, Germany).  
14-µm coronal sections through the region containing the hypothalamus were thaw-
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mounted onto gelatin-coated slides and prehybridized as previously described (Ottem et 
al., 2004).  
5.3.2 Cells and Culturing Methods 
 We used N42 cells, an immortalized hypothalamic neuronal cell line (Cellutions 
Biosystems, Inc.; Burlington, Ontario, Canada).  Cells were maintained at 37ᵒ C and 
5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% 
(v/v) Hyclone fetal bovine serum (FBS; Thermo Fisher Scientific, Rockford, IL), 100 
U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine (PS-Gln; GIBCO-
BRL; Gaithersburg, MA).  Once seeded cells were reached approximately 70% 
confluence, they were rinsed with phosphate buffered saline (PBS) and media was 
replaced with phenol red-free DMEM with 10% charcoal-stripped FBS and PS-Gln.  
After 24 h, cells were transfected using siRNA or expression vectors as described 
below.   
5.3.3 siRNA Experiments 
 N42 cells were transfected with 2 µM negative control or Pgrmc1 siRNA (Cat 
no. GS53328 and SI03650318, SABiosciences; Frederick, MD), using HiPerfect 
Transfection Reagent according to the manufacturer’s protocol (Qiagen, Valencia, CA).  
After 16 h, cells were treated with P4 (10 µM) for an additional 8 h prior to harvesting 
RNA.  The P4 treatment did not alter Pgrmc1 levels (Figure 5.8.3a), a finding also 
shown in granulosa cells (Peluso et al., 2010).  Total RNA was isolated using TRIzol 
reagent (Invitrogen; Carlsbad, CA) and Qiagen lipid easy kit (Qiagen) and 
manufacturer’s protocols.      
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5.3.4 Microarray Gene Expression Profiling 
 RNA from N42 cell siRNA experiments was used for Mouse Genome 430 2.0 
Gene Chip assay (Affymetrix; Palo Alto, CA) performed by the Keck Microarray 
Institute at Yale University.  RNA quality was assessed using an Agilent 2100 
Bioanalyzer and RNA 6000 Nano LabChips (Agilent Technologies, Palo Alto, CA).  
After data retrieval from the Keck Microarray Institute, Ingenuity Pathway Analysis and 
Pathway Studio (Ariadne; Rockville, MD) were employed to determine differences in 
gene expression that may differ among treatment groups.  To determine possible 
signaling pathways differentially affected by Pgrmc1 siRNA treatments, I used Pathway 
Studio, which utilizes the ResNet database based on the assumption that functionally 
related genes are co-transcribed.  I used Pathway Studio’s Gene Set Enrichment 
Analysis to identify candidate signaling pathways in which a higher number of pathway 
entities were significantly different between scramble and Pgrmc1 siRNA-transfected 
samples.  
5.3.5 Pgrmc1 Construct 
 N42 cells were transiently transfected using a pcDNA3.3 TOPO TA vector 
(Invitrogen; Carlsbad, CA) containing Pgrmc1 and using manufacturer’s protocol.  To 
generate the Pgrmc1 product, primers were obtained from Integrated DNA 
Technologies (Coralville, IA) and PCR reagents (Promega; Madison, WI).  The coding 
portion of the mouse Pgrmc1 sequence was produced using PCR primers: 5’-
TCATGGCTGCCGAGGATGT-3’ and 5’-TTATACATTCATTCTTCCGAGC-3’ 
corresponding to sequence 61-650 and included a stop signal (as denoted by underline).  
Gel-purified PCR products were cloned into the pcDNA™ 3.3-Topo® TA Cloning Kit 
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using manufacturer’s protocol (Invitrogen).  Transformants were analyzed for 
incorporation and orientation of the product using primers provided by manufacturer 
and sequencing.  I linearized the plasmid construct using Pvu I prior to transfection into 
N42 cells, and purified the linearized construct by phenol-chloroform extraction and 
ethanol precipitation.  The empty vector or Pgrmc1 expression construct was transfected 
into N42 cells using SuperFect and manufacturer’s protocol (Qiagen) and the resulting 
increase in Pgrmc1 RNA and protein was confirmed by QPCR and western blot (Figure 
5.8.6). 
5.3.6 Dual-luciferase Assays 
 The transcriptional activity of STAT3 was measured using dual-luciferase 
assays following transfection of N42 cells with Cignal™ STAT3 reporter construct 
(Cat. no CCS-9028L; SABiosciences).  In addition to STAT3-responsive elements 
upstream of the firefly luciferase construct, a Renilla luciferase construct was included 
in the same construct as an internal control for transfection efficiency normalization.  
To optimize transfection conditions, positive and negative control plasmids and 
manufacturer’s protocol were used (SABiosciences).  Combined transfection with 
siRNA was performed in order to determine the effect of Pgrmc1 knockdown on 
STAT3 activity in N42 cells.  Renilla and firefly luciferase activities in cell lysates were 
assayed using the Dual Luciferase reporter system (Promega) and measured on a 
Fluostar Optima Luminometer (BMG; Durham, NC).  Experiments were performed in 
triplicate and results are presented in Figure 5.8.5a.   
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5.3.7 Quantitative Reverse Transcriptase PCR (QPCR) 
 QPCR was used to verify that Pgrmc1 was knocked down by treatment with 
Pgrmc1 siRNA compared to scramble siRNA controls, and in order to validate 
outcomes of our microarray study.  Genes were chosen for validation based on their 
high and low levels of expression in N42 cells treated with scramble or Pgrmc1 siRNA 
in the presence of P4.  N42 RNA samples were generated using the identical treatment 
paradigm as described above for the original microarray experiment.  RNA was reverse 
transcribed into cDNA using QuantiTect Reverse Transcriptase Kit (Roche Diagnostics, 
Indianapolis, IN) and manufacturer’s protocol, which included a genomic DNA 
degradation step.  Primers were obtained from SABiosciences for nuclear receptor 
subfamily 4 group A member 1 (Nr4a1 ; 24496A),  interferon-induced protein with 
tetratricopeptide repeats 3 (IFIT3; 06008A), transglutaminase 2 (Tgm2; 40872E) and 
spectrin alpha 1 (Spna1; 32969A) and manufacturer’s protocol.  Primers for Pgrmc1 
and β-actin were obtained from Integrated DNA Technologies (Coralville, IA) and are 
listed in Table 5.7.1.  Reactions contained reagents from QuantiTect SYBR Green Kit, 
following manufacturer’s protocol (Roche Diagnostics, Indianapolis, IN).  These 
reactions were carried out using a Stratagene MX3000P thermocycler (Agilent 
Technologies, Wilmington, DE) and the following parameters: 95ᵒ C for 10 min, and 
40 cycles of 95ᵒ C for 30 sec, 55ᵒ C for 30 sec and 72ᵒ C for 30 sec.  MxPro™ QPCR 
analysis software (Agilent Technologies) was used to obtain fluorescence 
measurements.  Threshold cycle readings were used to calculate the relative amounts of 
target genes by normalizing them to the signal of β-actin after validating that β-actin 
mRNA levels did not differ among treatments.  Primer specificity was also validated 
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using 2% agarose gel electrophoresis to verify single products following the QPCR 
reaction.   
5.3.8 Western Blot  
 Protein was isolated from N42 cells lysates using radioimmunoprecipitation 
assay buffer (Boston BioProducts, Worcester, MA) containing 1% protease inhibitor 
cocktail (Calbiochem, San Diego, CA) and manufacturer’s protocol.  Protein 
concentrations were assessed using Pierce bicinchoninic acid protein assay (Thermo 
Fisher Scientific).  Ten-µg of protein per lane was electrophoresed on 4–15% Tris–HCl 
SDS-PAGE gradient gels (Biorad; Hercules, CA) and was transferred 
electrophoretically to Immobilon-P membranes (Millipore; Billerica, MA.)  Membranes 
were blocked in 5% skimmed dry milk in Tris-buffered saline plus 0.05% Tween-20 
(TBST; pH 7.4) for 1 h at room temperature on an orbital shaker, and then incubated 
overnight at 4ᵒ C with anti-Pgrmc1 antibody (1:1000; Proteintech Group, Chicago, IL) 
in TBST.  Membranes were washed in TBST for 30 min, followed by horseradish 
peroxidase-conjugated secondary antibody (anti-rabbit 1:10,000; Abcam, Cambridge, 
MA) for 1 h, and developed using Chemiluminescence HRP Substrate (Millipore).  
Blots were apposed to BioMax MR film (Kodak; Rochester, NY), and band intensities 
were quantified from developed films using densitometric software (GeneTools ver. 
3.07 SynGene; Cambridge, England).  Blots were re-probed with anti-β-actin (1:2000; 
Abcam) and anti-mouse antisera (1: 2000; Abcam) to provide protein loading controls.  
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5.3.9 Janus Kinase (JAK) and Signal Transducer and Activator of Transcription 3 
(STAT3) Inhibition 
 To determine whether activation of Jak2/STAT3 signaling pathway was 
upstream of Pgrmc1 siRNA effects on gene targets, N42 cells were treated with DMSO 
vehicle control or 10 nM JSI-124 (cat. no. C4493; Sigma).  JSI-124 is a cell-permeable 
compound that specifically inhibits Jak2 and STAT3 by suppressing their 
phosphorylation status (Sun et al., 2005, Shi et al., 2006).  JSI-124 exposure decreases 
STAT3 DNA binding and STAT3-mediated gene expression, yet has no effect on the 
activity of Src, Akt, ERK, or JNK pathways (Blaskovich et al., 2003).  The dose of 10 
nM was selected based on preliminary reports of JSI-124 effective doses in other cell 
lines, and a dose-response of N42 cell viability following 24 h exposure to vehicle, 
1x10-6 M, 1x10-5 M, 1x10-4 M and 1x10-3 M JSI-124.  A trypan blue exclusion assay was 
used to assess cell viability as previously described (Mishell and Shiigi, 1980) and cell 
phenotype changes were also recorded (Figure 5.8.4a).    
5.3.10 Oligodeoxynucleotidyl Probe Preparation 
 Sense and antisense oligodeoxynucleotidyl probes were obtained from 
Integrated DNA Technologies (Coralville, IA) as listed in Table 1.  Using terminal 
deoxynucleotidyl transferase (Roche, Indianapolis, IN), sequences were 3′-end labeled 
with [α33P]-dATP (PerkinElmer, Waltham, MA) as described previously (Petersen et 
al., 1989).  I purified the probe by phenol-chloroform extraction and ethanol 
precipitation and washed the pellet with 70% ethanol before suspending the probe in 25 
µl TE (10 mM Tris-HCl; pH 8.0, 1 mM EDTA). 
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5.3.11 In Situ Hybridization Histochemistry (ISHH) 
 To determine the relative localization of Pgrmc1 and validated gene targets, 
radioisotopic probes (0.5×106 cpm) were applied to prehybridized brain sections in 20 
µl hybridization buffer.  This buffer contained 4×SSC (1×SSC=0.15 M NaCl/0.015 M 
sodium citrate, pH 7.2), 50% (v/v) formamide, 10% (w/v) dextran sulfate, 250 µg/ml 
yeast tRNA, 1× Denhardt's solution, 500 µg/ml heparin sodium salt, 0.1% sodium 
pyrophosphate and 0.05 M dithiothreitol added freshly before use.  After covering 
sections with glass coverslips, slides were hybridized for 16 h at 37 °C in humidified 
plastic boxes.  Slides were removed from 37 °C and coverslips were floated off in 
1×SSC.  Sections were washed four times for 15 min each in 2×SSC-50% formamide 
solution at 40 °C, followed by four washes, 15 min each, in 1×SSC.   All sections were 
rinsed in double-distilled water, dehydrated briefly in 70% ethanol, and air-dried.  For 
signal detection, slides were apposed to BioMax MR film (Kodak) and autoradiograms 
were developed by an X-ray film processor.  I then used NTB2 emulsion and standard 
autoradiographical procedures to visualize probes for Nr4a1 (Kodak; 10 d exposure) 
and counterstained brain sections using thionin in order to determine whether Nr4a1 
signal was confined to cell bodies.  All images were acquired using BioQuant Imaging 
Software (Bio-Quant Inc., Nashville, TN, USA) and a CCD videocamera (QImaging 
QICAM FAST color, Surrey, BC, Canada).  
5.3.12 Statistics 
  Data is expressed as means ± SEM and all data shown is the result of at least 
three replicates of three or more independent runs for each assay.  Treatment effects 
were evaluated using one-way ANOVA, except for validation of QPCR studies using 
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siRNA and P4 treatments which required two-way ANOVA.  Bonferroni t-tests were 
used for post hoc analyses of treatment effects.  For QPCR studies, Ct values from 
duplicates of each sample were normalized to those of β-actin and analyzed using the 
∆∆Ct method (Livak and Schmittgen, 2001) and treatment effects were evaluated using 
two-way ANOVA.  Dual luciferase experiments were analyzed by unpaired t tests. 
5.4 Results 
5.4.1 Pgrmc1 siRNA Experiments 
 Pgrmc1 expression was depleted by treatment with 2 µM Pgrmc1 siRNA 
compared to scramble siRNA controls as determined by QPCR (Fig. 5.8.1a) and 
western blotting (Fig. 5.8.b).  Knockdown of Pgrmc1 was significant at 16 h post-
transfection with siRNA, and persisted at 24 h (Fig 5.8.1a).  Following optimization of 
the siRNA transfection protocol, RNA was prepared for microarray analyses and 
validation studies. 
5.4.2 Identification of Novel Target Genes by Microarray Analyses 
 Genes identified using Affymetrix whole-genome microarrays are displayed 
using a heat map and fold change analyses (Fig. 5.8.2a).  To generate fold changes 
between scramble (control) and Pgrmc1 siRNA-transfected groups, the mean expression 
values of samples transfected with Pgrmc1 siRNA were log2 transformed and 
normalized to those of the control group.  The raw expression values of gene expression 
among groups were used to run gene set enrichment analysis in order to provide a 
ranking of predicted canonical pathways that differ when Pgrmc1 expression was 
decreased by the use of Pgrmc1 siRNA (Table 5.7.3).  The top-ranked pathway was 
IL6R and STAT3 signaling and is displayed in Figure 5.8.2b with relative expression 
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data between scramble (control) and Pgrmc1 siRNA-transfected groups as indicated 
(Fig. 5.8.2a). 
5.4.3 Validation of Microarray Findings by QPCR 
 Several gene candidates differentially expressed following Pgrmc1 depletion 
were validated by QPCR in N42 cells.  In these experiments, N42 cells were also 
exposed to 8 h of 10 nM P4, and levels of Pgrmc1 mRNA were validated to be 
decreased by transfection with Pgrmc1 siRNA compared to scramble (controls) 
(Fig.5.8.3a).  Pgrmc1 depletion decreased levels of mRNA encoding pro-survival genes 
Tgm2 (Fig.5.8.3b) and Spna1 (Fig.5.8.3.c).  Additional gene candidates were selected 
and validated to be increased by Pgrmc1 depletion, including genes implicated in 
apoptotic pathways including Nr4a1 (Fig. 5.8.3d) and IFIT3 (Fig. 5.8.3.e).  Regulation 
of Pgrmc1 and all gene targets was P4-independent at the dose tested. 
5.4.4 Transfection of Pgrmc1 Expression Construct  
 To determine if Pgrmc1 levels resulted in the changes to mRNA levels as shown 
in siRNA depletion studies, Pgrmc1 expression constructs were used to increase 
Pgrmc1 expression in N42 cells.  Transfection of empty vector control or Pgrmc1 
expression constructs into N42 cells increased levels of Pgrmc1 mRNA (Fig. 5.8.4a) 
and protein (Fig. 5.8.4b).  In these experiments, Pgrmc1 over-expression causes similar 
increases in levels of mRNA encoding Tgm2 (Fig. 5.8.4c) and Spna1 (Fig. 5.8.4d).  
Over-expression of Pgrmc1 appeared to decrease Nr4a1 levels (Fig. 5.8.4.e), and had no 
effect on IFIT3 mRNA (Fig 5.8.4.f).  
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5.4.5 Pgrmc1 Levels Regulate STAT3 Activity 
 In accordance with pathway candidates identified by microarray analyses, the 
relative activity of STAT3 was investigated using a STAT3 reporter construct.   Dual-
luciferase assays were performed on N42 cells cotransfected with a STAT3 reporter and 
scramble (control) or Pgrmc1 siRNAs.  After 24 h of transfection, cells treated with 
Pgrmc1 siRNA showed increased STAT3 activation relative to scramble siRNA 
controls, (Fig. 5.8.5).    
5.4.6 STAT3 Inhibitor JSI-124 Alters Pgrmc1, Nr4a1 and IFIT3 mRNA Levels 
 Treatment of N42 cells with doses of JSI-124 resulted in rounding of the cells 
and cell death as determined by trypan blue exclusion assay (Fig. 5.8.6a), therefore a 
dose of 10 nM was chosen as to minimize changes in cell morphology and viability.  
Treatment of N42 cells with JSI-124 for 8 h decreased Pgrmc1 mRNA levels compared 
to vehicle controls (Fig.5.8.6a).  This treatment had no effect on levels of mRNA 
encoding Tgm2 (Fig. 5.8.6c) or Spna1 (Fig 5.8.6d), but increased Nr4a1 mRNA levels 
(Fig. 5.8.6e) and decreased IFIT3 mRNA levels (Fig.5.8.6f). 
5.4.7 ISHH Studies Reveal That Pgrmc1, STAT3, and Nr4a1 Localize to the 
Hippocampus and Paraventricular Nucleus of Mouse Brain 
 ISHH studies were performed in order to determine the anatomical localization 
of Pgrmc1 and whether Pgrmc1-coregulated genes identified in N42 cells were present 
in the same brain regions.  Pgrmc1 signal was especially abundant in neuroendocrine 
nuclei including the medial preoptic area (Fig 5.8.7g), suprachiasmatic nucleus (Fig. 
5.8.7j), paraventricular nucleus (Fig. 5.8.7m) and hippocampus (Fig. 5.8.7p).  Nr4a1 
signal was high in the cortex and rostral striatum (Fig. 5.8.7 e, h, k), and very strong in 
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the paraventricular nucleus (Fig. 5.8.7n) and hippocampus (Fig.5.8.6q).  STAT3 ISHH 
signal was very diffuse but appeared to overlap the expression of Nr4a1 and Pgrmc1 in 
the paraventricular nucleus (Fig. 5.8.7o) and hippocampus (Fig. 5.8.7r).  ISHH signal 
for STAT3 and Nr4a1 in the paraventricular nucleus have been reported previously 
(Parkes et al., 1993, Hubschle et al., 2001).  The specificity of the Nr4a1 ISHH signal in 
the paraventricular nucleus was further confirmed by autoradiographical detection using 
emulsion as shown in Figure 5.8.8a.  Specific ISHH signal IFIT3, Spna1, and Tgm2 
was not detected (data not shown). 
5.5 Discussion 
 We found that Pgrmc1 levels regulate basal levels of mRNA encoding several 
novel gene targets in neural cells, including Spna1, Tgm2, Nr4a1 and IFIT3, indicating 
a novel role of Pgrmc1 in regulating diverse genes in neural cells.  While mRNA levels 
of Tgm2 and Spna1 closely matched those of Pgrmc1, levels of Nr4a1 and IFIT3 were 
increased following Pgrmc1 depletion, suggesting that Pgrmc1 exerts repressive effects 
on gene expression.  Our novel findings that Pgrmc1 regulates STAT3 activation 
indicate that Pgrmc1 levels may regulate basal activation of pathways critical for cell 
proliferation.  Finally, the results of our ISHH studies show that Pgrmc1, Nr4a1 and 
STAT3 mRNA signal is enriched in the hippocampus and paraventricular nucleus, in 
line with the idea that Pgrmc1 levels may regulate Nr4a1 abundance and STAT3 
activation in vivo.  Interestingly, the effects of Pgrmc1 depletion on Tgm2, Spna1, 
Nr4a1 and IFIT3 were P4-independent, suggesting that Pgrmc1 exerts important 
functions at the cellular level even in the absence of P4.  Taken together, our findings 
provide a novel role of Pgrmc1 in regulating basal levels of novel gene targets and 
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STAT3 signaling, and indicate that Pgrmc1 may function as a pro-survival factor that 
regulates cell maintenance and proliferation.   
 Our results demonstrate that Pgrmc1 levels regulate levels of several genes 
involved in cell cycle progression and proliferation, which may provide insight into the 
role of this molecule in mitotic neurons rather than in adults.  While this was not the 
original intention of the study, the validated gene targets are relevant to pro-survival 
functions in developing neural cells.  For example, Pgrmc1 repression decreased levels 
of Spna1, a gene known for maintenance of cytoskeletal structures and for the 
regulation of plasma membrane components (Beck and Nelson, 1996).  Spna1 is a 
molecule found in all major cell types of the brain and interacts with proteins important 
for synaptic function (Krebs et al., 1987, Sikorski et al., 1991, Clark et al., 1994).  This 
ubiquitous expression in brain cells is a possible reason for why specific ISHH Spna1 
signal was not detected in this study, but as the genes identified point to roles in cell 
maintenance and proliferation, it is possible that the effect of Pgrmc1 on Spna1 levels is 
more pertinent to studies in the developing nervous system.  
 In addition to coregulation of Spna1, we found that Pgrmc1 levels appeared to 
dictate Tgm2 mRNA abundance, which is interesting because Tgm2 is heavily 
implicated in cell survival.  Tgm2 levels are carefully controlled as this multifunctional 
enzyme regulates cell viability by controlling protein scaffold cross-linking and 
stabilizing integrin (Lorand and Graham, 2003, Janiak et al., 2006).  Although we and 
others did not detect specific localization of Tgm2 mRNA by ISHH mouse brain (data 
not shown), Tgm2 is present in the brain as identified by QPCR and enzymatic activity 
assays (Gilad and Varon, 1985, Bailey et al., 2004).  Much like Pgrmc1, Tgm2 
 107 
 
expression is sharply increased by traumatic brain injury (Gilad et al., 1985, Tolentino 
et al., 2002, Labombarda et al., 2003, Guennoun et al., 2008), indicating that these 
genes may be required for recovery processes.  Importantly, Tgm2 is also important for 
neural development, in line with the idea that it may play important roles in actively-
dividing cells (Spiteri et al., 2007).    
 We found that Pgrmc1 depletion increased levels of Nr4a1 and IFIT3 mRNA, 
which may indicate a repressive role of Pgrmc1 on transcription of these genes and 
support the notion that Pgrmc1 is important for cell viability.  Both Nr4a1 and IFIT3 
mediate apoptosis (Chan et al., 1998a, Chintharlapalli et al., 2005, Stawowczyk et al., 
2010); therefore, Pgrmc1 repressive effects on their expression may represent a pro-
survival function.  These genes have distinct functions in other cells that may yield 
clues as to their neural roles.  Pgrmc1 regulation of Nr4a1 is especially interesting as 
both genes regulate aspects of P4 metabolism, though they have not been previously 
linked.  Specifically, Nr4a1 is a member of the nuclear receptor superfamily that acts as 
a transcription factor and induces expression of 20-α-HSD, an enzyme that decreases 
progesterone levels.  While a steroid metabolism role is suggested by studies on Nr4a1 
in adult cells, in mitotic cells, Nr4a1 is specifically expressed during the G0/G1 cell 
cycle re-entry phase (Hazel et al., 1988).  Although less is known regarding the function 
of IFIT3, it is induced by immunogenic stimuli and is STAT-dependent (Wang and 
Campbell, 2005), in line with our finding that STAT3 inhibition decreases IFIT3 
mRNA levels.  IFIT3 expression is difficult to localize to the brain without 
immunogenic stimuli (Wacher et al., 2007) , a possible reason for why specific IFIT3 
RNA signal was not detectable in our ISHH studies (data not shown).  Thus, Pgrmc1’s 
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repressive effect on levels of Nr4a1 and IFIT3 are consistent with pro-survival functions 
in neural cells.      
 Our finding that Pgrmc1 regulates STAT3 signaling also supports a role of 
Pgrmc1 in cell cycle progression, but this conclusion is likely dependent on cell-type.  
Studies using cell lines show that STAT3 pathway activation is important for cell cycle 
progression, and this pathway is also important in mediating immune responses, 
differentiation and apoptosis (Nakajima et al., 1996, Fukada et al., 1998).  By inhibiting 
STAT activation using JSI-124, we were able to see a decrease in mRNAs encoding 
Pgrmc1 and IFIT3.  In the case of IFIT3, this was a predicted result as IFIT3 has been 
shown to be increased coordinately with JAK/STAT signaling (Darnell, 1998).  The 
observed increase in Nr4a1 may be a compensatory rise in response to declining 
Pgrmc1 levels.  The observed decreases in levels of Pgrmc1 mRNA suggest that 
Pgrmc1 levels and STAT signaling are coordinately regulated and useful indicators of 
cell proliferation in vitro. Indeed, this idea may be more relevant for actively-dividing 
cells rather than for post-mitotic neurons.   
 Although STAT3 signaling correlates to cell proliferation, STAT3 signaling is 
integral to a host of physiological effects depending on the tissue.  Importantly, neural 
STAT3 signaling is important for mediating leptin actions in hypothalamic nuclei to 
control body weight (Hubschle et al., 2001).  Thus, our findings of high Pgrmc1 and 
STAT3 ISHH signal in the paraventricular nucleus may reflect a role in regulating basal 
responses to leptin.  The overlap of these with Nr4a1 expression is also interesting as 
Nr4a1 is induced by stress.  Taken together, the role of Pgrmc1 appears to be important 
 109 
 
for restraining STAT activity, and may be relevant to STAT signaling in the brain, 
though this possibility must be tempered by future research. 
  In conclusion, neural expression of Pgrmc1 may be relevant for a host of cell 
processes, including regulation of STAT pathway activation and the expression of 
several gene targets.   Indeed, our present work contributes to a growing body of 
evidence that STAT3 pathways are tightly regulated by many diverse cellular factors.  
Extensive work in the field of JAK/STAT signaling shows that STAT3 signaling is also 
constrained by a large family of diverse proteins (Lufei et al., 2003; Zhange et al., 2003; 
Wormald and Hilton, 2004).  Our findings suggest novel cross-talk signaling between 
Pgrmc1 and STAT3 signaling and suggest that novel gene targets, including Spna1, 
Tgm2, Nr4a1, and IFIT3, may be important Pgrmc1 targets in mitotic neurons.  Given 
the relevance of STAT signaling in the paraventricular nucleus, a brain region in which 
we identified high levels of Pgrmc1 and Nr4a1, a potential role of Pgrmc1 may also be 
implicated involving stress and body weight homeostasis. 
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5.6.1: Primers Used in QPCR Studies 
NCBI Gene 
Name   and 
Refseq ID 
Primer sequences 5’- 3’ Antisense to bases 
Amplicon 
(bp) 
Actb 
NM_007393 
GGCTGTATTCCGCCTCCATCG 163 – 182 
154 
CCAGTTGGTAACAATGCCATG 316 – 296 
Pgrmc1 
NM_016783 
TCCATGTCTGCATGTGGACACTCT 1247 – 1270 
198 
ACCTGTTCCTGCCCTGTAATTCCT 1444 – 1421 
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 5.6.2: Sequences for Oligodeoxynucleotidyl Probes Used in ISHH Studies 
NCBI   
Gene and 
Refseq ID 
Oligodeoxynucleotide Sequences 5’- 3’ 
Anti-
sense       
to 
bases 
Pgrmc1 
NM_016783 
TGGGCTTGTTTTAGAATACAGCATGGCTACACGCTGATCCTTCTTCAT 1070- 1023 
STAT3 
NM_213659 TCACAAGGTCGATGATATTGTCTAGCCAGACCCAGAAGGAGAAGCCCT 
1996-
1949 
Nr4a1 
NM_010444 TCGTTGCTGGTGTTCCATATTGAGCTTGAATACAGGGCATCTCCAGCC 
151- 
104 
IFIT3 
NM_010501 GTGCTCTGTCTGCTTTAAGCTCCATTCCCTACATGATTAGTAATGAGG 
1678- 
1631 
Spna1 
NM_011465 TGTCCAGTCCACTTCAAATAGGAATGTCAGAAATGTGAATGTGGCAAA 
97- 
50 
Tgm2 
NM_009373 
TTAGCGACCAGCGTGGATATTTAAGGCTCGTTCTGTGAAATCTAGTCT 3129-3082 
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 5.6.3: Gene Set Enrichment Analysis 
 
Pathways Identified Using Microarray Data: Scramble versus Pgrmc1 siRNA 
Rank Pathway Name p-value 
1 IL6R and STAT3 Signaling 0.019 
2 Gonadotrope Cell Activation 0.026 
3 Urokinase receptor and STAT Signaling 0.040 
4 IFNAR and STAT Signaling 0.041 
5 CNTFR and STAT3 Signaling 0.045 
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5.7.1 Pgrmc1 siRNA Decreased Levels of Pgrmc1 mRNA and Protein  
A 
 
B          C 
 
 
 
 
 
Figure 5.7.1: Pgrmc1 siRNA Decreased Levels of Pgrmc1 mRNA and Protein.  N42 
cells transfected with either scramble (control) or Pgrmc1 siRNA had decreased 
levels of Pgrmc1 mRNA at 16 and 24 h post-transfection as determined by 
QRTPCR (A).  Treatment with Pgrmc1 siRNA for 24 h decreased Pgrmc1 protein 
as determined by western blot (B) to approximately 50% that of scramble siRNA 
controls (C).  ** p ≤ 0.01.   
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 5.7.2 Analyses of Microarray Data 
A               B       
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7.2: Analyses of Microarray Data.  Heat map representation of a subset of 
differentially expressed genes in N42 cells following transfection with scramble 
(control) or Pgrmc1 siRNA (A).  Gene Set Enrichment Analysis identified the 
IL6R and STAT signaling pathway as a candidate pathway affected by Pgrmc1 
siRNA transfection relative to scramble (control) (B).  Shading of pathway entities 
indicates the relative gene expression of scramble (control) versus Pgrmc1 siRNA-
transfected N42 cells.  As illustrated, Pgrmc1 siRNA modestly increased all 
pathway members relative to scramble siRNA.    
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 5.7.3 Validation of Microarray Findings by QPCR 
 
Figure 5.7.3: Pgrmc1 co-regulates multiple gene targets in a P4-independent 
manner.   N42 cells transfected with scramble (control) or Pgrmc1 siRNA were 
treated with vehicle control (Veh) or 10 nM P4.  Pgrmc1 siRNA transfection 
depleted Pgrmc1 mRNA levels to 50% that of controls (A).  Pgrmc1 co-regulated 
mRNA levels of Tgm2 (B) and Spna1 (C).  Pgrmc1 depletion increased levels of 
Nr4a1 (D) and IFIT3 (E) in a P4-independent manner.  *** = p ≤ 0.001   
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 5.7.4 Pgrmc1 Construct Transfection Increased Pgrmc1 Expression 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7.4: QPCR was used to determine relative levels of mRNA in N42 cells 
transfected with empty vector (control) or Pgrmc1 construct.  Pgrmc1 mRNA (A) and 
protein (B) levels were increased by transfection with a Pgrmc1 construct compared to 
controls. * = p ≤ 0.05.  Pgrmc1 co-regulated mRNA levels of Tgm2 (C) and Spna1 (D).  
Pgrmc1 overexpression decreased levels of Nr4a1 (E) but had no effect on levels of mRNA 
encoding IfitT3 (F). * = p≤ .05; ** = p≤ .01; *** = p≤ .001. 
 
B 
 117 
 
5.7.5 Pgrmc1 Depletion Stimulates STAT3 Activation  
     
 
Figure 5.7.5: Depletion of Pgrmc1 increased STAT3 activation.  (A) N42 cells were 
cotransfected with a STAT3-luciferase reporter and either scramble (white bar) or 
Pgrmc1 (black bar) siRNA for 24 h prior to assaying luciferase activities.  The 
STAT3 construct contained multiple STAT3-responsive elements upstream of 
luciferase and an internal Renilla reporter for normalization, and relative 
luciferase activity of cell lysates is shown.  ** = p ≤ 0.01.     
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5.7.6 Inhibition of JAK/STAT in N42 Cells 
A 
 
 
 
 
 
 
Figure 5.7.6: Effects of JAK/STAT Inhibition for 8 h.  N42 cells exposed to varying 
doses of JSI-124 exhibit cell rounding and cell death as determined by phenotypic 
and trypan blue exclusion assays (A).  Exposure to 10 nM JSI-124 for 8 h reduced 
levels of Pgrmc1 mRNA (B), had no effect on levels of mRNA encoding Tgm2 (C) 
or Spna1 (D), modestly increased Nr4a1 mRNA levels (E), and reduced IFIT3 
mRNA levels (F).  * = p≤ .05; ** = p≤ .01; *** = p≤ .001. 
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5.7.7 Localization of Pgrmc1, Nr4a1 and STAT3 mRNA in Mouse Brain   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7.7: Film autoradiograms of sections hybridized to 33P-labeled 
oligodeoxynucleotidyl probes for Pgrmc1, Nr4a1 and STAT3.  Representative 
sections hybridized to sense strand probes are shown in the row one (A, B and C), 
and antisense probes were used all other sections shown.  Black arrows show high 
signal intensities in the paraventricular nucleus for Pgrmc1 (M), Nr4a1 (N) and 
STAT3 (O) and the hippocampus for Pgrmc1 (P), Nr4a1 (Q) and STAT3 (R).   
Scale bar = 350 µm. 
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 5.7.8 Cell-specific Nr4a1 ISHH Signal in the Paraventricular Nucleus 
 
Figure 5.7.8: Cell-specific Nr4a1 ISHH Signal in the Paraventricular Nucleus.  
Nr4a1 ISHH signal is highly specific for cells of the paraventricular nucleus as 
indicated by silver grains (33P-labeled oligodeoxynucleotidyl probes antisense for 
Nr4a1).  The black arrows indicate silver grain signal.  Scale bar = 30 µm; 3V = 
Third ventricle. 
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CHAPTER 6 
CONCLUDING REMARKS 
6.1 Main Findings Concerning the Neural Roles of Pgrmc1 
 The series of studies presented herein provide significant new insight into the 
neural roles of Pgrmc1.  According to my working premise, I have identified factors 
that implicate Pgrmc1 in the context of neural function.  As a molecule primarily 
studied in ovarian cells, Pgrmc1 has now emerged as a P4 candidate signaling molecule 
in the brain.  As the first to map and compare the anatomical distributions of Pgrmc1, 
Pgrmc2, Serbp1, Paqr7 and Paqr8, my findings are consistent with the idea that these 
signaling molecules may regulate neuroendocrine functions.  Moreover, these studies 
strengthened the concept that Pgrmc1 interacts with Serpb1 in many brain nuclei as they 
were shown to display strikingly similar distributions through much of the forebrain.  
Furthermore, based on the overlapping distributions of the classical Pgr with Pgrmc1, 
my work provides the first indication that P4 may influence neural functions through 
multiple signaling molecules.   
 In further support of reproductive roles of Pgrmc1, I examined the regulation of 
mRNA levels by ovarian hormones and found that these are regulated in a nuclei-
specific manner.  As these specific neuroendocrine brain regions control diverse 
reproductive functions, the finding that Pgrmc1 expression responded to ovarian 
hormones depending on brain region is consistent with its ability to mediate diverse 
responses depending on cell type.  In further support of important neural functions, the 
pattern of regulation of binding partners Pgrmc1 and Serbp1 was nearly identical in 
several nuclei examined, suggesting that they may work together to mediate P4 effects.  
 141 
 
Comparisons of gene expression patterns were facilitated by examining the regulation 
of Paqr7, Paqr8, the classical estrogen receptor α (Esr1) and Pgr.  My finding that 
patterns of regulation for Pgrmc1 and Pgr overlap in some regions suggests that these P4 
signaling molecules may act together, but their overlapping distribution were not 
complete.  The presence of Pgrmc1 in Pgr-deficient hypothalamic nuclei may point to 
an independent role of Pgrmc1 in the neuroendocrine effects of P4.   
 Key findings from our studies using dual-label in situ hybridization are the first 
to show that GABAergic AVPV neurons contain abundant Pgrmc1 and Serbp1.   Given 
the indispensable role of these neurons in the preovulatory LH surge, these findings 
indicate that Pgrmc1 may be important in the neural control of ovulation.  In addition to 
their presence in GABAergic neurons, Pgrmc1 was specifically found within Serbp1-
containing neurons, which emphasizes the likelihood that these molecules function 
together as part of a P4 –receptor complex as demonstrated in other cell types. 
 The cellular roles of Pgrmc1 were investigated using a hypothalamic neural cell 
line, and my results demonstrated that Pgrmc1 levels dictate the expression of several 
genes.  By validating microarray findings, I found that Pgrmc1 coregulated several 
novel genes targets, including Tgm2 and Spna1.  Given that these genes have important 
anti-apoptotic actions, it is likely that regulation of these genes is important for cell 
viability.  In light of these data, I propose a critical action of Pgrmc1 in mediating pro-
survival functions through transcriptional regulation of levels of several target genes.  In 
further support of this notion, Pgrmc1 levels also had a reciprocal effect on levels of 
mRNA encoding Nr4a1 and IFIT3, gene targets involved in apoptotic signaling (Liu et 
al., 1994, Guenterberg et al., 2010).   In further pro-survival functions, I found evidence 
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that Pgrmc1 affects basal STAT3 activation levels.  Interestingly, STAT inhibition 
decreased Pgrmc1 levels as well, suggesting cross-talk between Pgrmc1- and STAT3-
dependent pathways.      
 Interestingly, levels of Pgrmc1-coexpressed genes were not sensitive to P4 in our 
hypothalamic cell line, demonstrating that Pgrmc1 exerts P4-independent effects on 
gene expression.  While it is possible that Pgrmc1 exerts these important effects in 
differentiated neurons, instead Pgrmc1 actions may be different in mitotic cells such as 
our hypothalamic cell line.  Although we found that the paraventricular nucleus 
contains high levels of Pgrmc1 and specific expression of STAT3 and Nr4a1, the role of 
the gene targets identified suggests that Pgrmc1 may affect cell viability.  Furthermore, 
this idea could be more relevant in mitotic cells during development than in 
differentiated adult neurons of the hypothalamus.    
 These novel insights into Pgrmc1 function expand the potential roles of this 
signaling molecule, and have raised important possibilities as to Pgrmc1 roles in nuclei 
that rely upon STAT3 activation for neurobehavioral outcomes.  Moreover, by 
identifying novel gene targets sensitive to Pgrmc1 levels in a neural cell line, this work 
indicates a P4-independent role of Pgrmc1 that may impact the developing brain.   
Taken together, the work presented here links Pgrmc1 to cell signaling cascades and 
gene targets important for neural function, suggesting that Pgrmc1 may be important for 
a broad array of pro-survival actions in neurons.    
 In further support of Pgrmc1 as a pro-survival gene, Pgrmc1 levels are 
overexpressed by cancerous cells (Rohe et al., 2009, Peluso et al., 2008).  In fact, 
Pgrmc1 levels have been proposed to promote tumorigenesis (Ahmed et al., 2010) and 
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6.2 Future Directions 
  
 While the anatomical localization studies and AVPV GABAergic expression of 
Pgrmc1 strongly imply a role in reproduction, an understanding of Pgrmc1 function will 
be greatly aided by the use of specific antagonists.  A putative Pgrmc1 ligand known as 
AG-205 has been identified using the Arabidopsis thaliana homolog of Pgrmc1 
(Yoshitani et al., 2005).  This aromatic compound was used in further studies in breast 
cancer cells, and it appears to bind Pgrmc1 and inhibit cell viability and cell cycle 
progression in a Pgrmc1-dependent manner (Ahmed et al., 2010).  While the specificity 
of AG-205 to Pgrmc1 requires further validation, this molecule may be used in future 
studies to investigate the neural role of Pgrmc1.   
 Additional work using transgenic animals will greatly aid our understanding of 
Pgrmc1 function.  A role in important aspects of neural development has been 
suggested by several studies (Sakamoto et al., 2004, Runko et al., 1999), so the use of 
tissue-specific conditional knockouts may be better suited to investigate the role of 
Pgrmc1 in specific neural subpopulations.  Despite our findings that GABAergic AVPV 
neurons express Pgrmc1, this subpopulation is a difficult target due to ubiquitous 
expression of GABA in many brain regions; therefore, a future possibility may be to 
target kisspeptin neurons.  These neurons are found as a very discrete population in the 
medial AVPV along the third ventricle, and are critical for the LH surge mechanism in 
the mouse (Gottsch et al., 2004).  Another possibility may be a Pgrmc1 knockout within 
neurons expressing steroidogenic factor-1, which would deplete Pgrmc1 expression 
primarily within neurons of the ventromedial nucleus.  This idea may be another 
possibility worthy of future studies, particularly if feminine sex behaviors were 
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examined.  Taken together, the characterization, regulation, and specific expression of 
Pgrmc1 in neurons important for control of reproduction provides an exciting 
opportunity for future studies using transgenic mice. 
6.3 Closing Remarks 
 While the neural role of Pgrmc1 remains unclear, the full spectrum of research 
on this molecule reflects diverse implications of Pgrmc1 function.  Based on its 
expression in a wide range of tissues, Pgrmc1 is likely to be important for a variety of 
physiological processes.  In virtually all cell lines tested, Pgrmc1 exerts pro-survival 
actions, suggesting that this molecule is required for cell proliferation and viability.  As 
a highly expressed gene in terminally differentiated neurons, Pgrmc1 may exert 
additional effect such as mediating P4 signaling or metabolism.  The present work also 
suggests that Pgrmc1 levels may modulate signaling cascades in adult neurons.  Thus, 
the results provided advance our understanding of Pgrmc1 in the context of neural 
function and yield new potential avenues of study for this molecule.      
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